Clicky

Friday, November 20, 2026
All public companies · Official EDGAR

AGIOAGIOS PHARMACEUTICALS, INC.

Nasdaq · CIK 0001439222
Filer categoryLarge accelerated filer
Entity typeoperating
SIC2834 Pharmaceutical Preparations
FY end1231
XBRL facts400

Identity from submissions API

NameAGIOS PHARMACEUTICALS, INC.
CIK0001439222
TickersAGIO
ExchangesNasdaq
Entity typeoperating
CategoryLarge accelerated filer
SIC2834 Pharmaceutical Preparations
EIN000000000
LEI—
Fiscal year end1231
State of incorporationDE DE
Phone617-649-8600
Website—
Investor website—
Owner org03 Life Sciences
Flags—
Description—
Insider transactions (issuer)1
Insider transactions (owner)0

Former names

  • AGIOS PHARMACEUTICALS INC (2008-07-01T04:00:00.000Z → 2019-07-16T04:00:00.000Z)
Business address
88 SIDNEY STREET
CAMBRIDGE
MA
02139
MA
Mailing address
88 SIDNEY STREET
CAMBRIDGE
MA
02139
MA

EDGAR has no company-logo API. Website field is shown when the filer provided one.

Financialist coverage

SEC filings

1307 filing rows loaded from submissions recent; extra archives: CIK0001439222-submissions-001.json (306 filings, 2008-07-01 to 2016-01-03).

FiledFormDocumentItemsAccessionFile no.FilmActSizeXBRLiXBRL
2026-11-16 SCHEDULE 13G/A xslSCHEDULE_13G_X02/primary_doc.xml 0001104659-26-128410 005-87570 261561808 34 21141
2026-11-16 SCHEDULE 13G/A xslSCHEDULE_13G_X02/primary_doc.xml 0000902664-26-004571 005-87570 261560456 34 10560
2026-11-13 SCHEDULE 13G xslSCHEDULE_13G_X02/primary_doc.xml 0000895421-26-000341 005-87570 261553962 34 7907
2026-11-05 10-Q 10-Q 0001439222-26-000131 001-36014 261525223 34 6640607 1 1
2026-11-05 8-K 8-K 2.02,9.01 0001439222-26-000129 001-36014 261524596 34 325135 1 1
2026-10-28 4 FORM 4 0001439222-26-000124 8970
2026-10-26 144 xsl144X01/primary_doc.xml 0001950047-26-010399 001-36014 261486045 33 6865
2026-10-23 4 FORM 4 0001439222-26-000122 13738
2026-10-22 144 xsl144X01/primary_doc.xml 0001950047-26-010371 001-36014 261479306 33 6178
2026-10-21 144 xsl144X01/primary_doc.xml 0001950047-26-010353 001-36014 261476803 33 5495
2026-08-06 4 FORM 4 0001439222-26-000120 5348
2026-08-04 144 xsl144X01/primary_doc.xml 0001950047-26-007592 001-36014 261238651 33 6381
2026-08-03 SCHEDULE 13G/A xslSCHEDULE_13G_X02/primary_doc.xml 0000908834-26-000367 005-87570 261230546 34 47408
2026-07-30 10-Q 10-Q 0001439222-26-000118 001-36014 261220651 34 6519319 1 1
2026-07-30 8-K 8-K 2.02,9.01 0001439222-26-000115 001-36014 261220025 34 332170 1 1
2026-07-10 4 FORM 4 0001439222-26-000112 7070
2026-07-02 SCHEDULE 13G xslSCHEDULE_13G_X02/primary_doc.xml 0001104659-26-080304 005-87570 261150939 34 21630
2026-07-02 4 FORM 4 0001439222-26-000110 8992
2026-07-01 144 xsl144X01/primary_doc.xml 0001439222-26-000108 001-36014 261145165 33 5011
2026-06-23 4 FORM 4 0001439222-26-000107 11588
2026-06-23 4 FORM 4 0001439222-26-000105 11581
2026-06-23 4 FORM 4 0001439222-26-000103 12306
2026-06-23 4 FORM 4 0001439222-26-000101 11636
2026-06-23 4 FORM 4 0001439222-26-000099 11576
2026-06-23 4 FORM 4 0001439222-26-000097 11768
2026-06-23 4 FORM 4 0001439222-26-000095 11543
2026-06-23 4 FORM 4 0001439222-26-000093 11570
2026-06-23 4 FORM 4 0001439222-26-000091 8249
2026-06-23 4 FORM 4 0001439222-26-000089 8251
2026-06-23 4 FORM 4 0001439222-26-000087 8227
2026-06-23 4 FORM 4 0001439222-26-000085 8223
2026-06-23 4 FORM 4 0001439222-26-000083 8253
2026-06-23 4 FORM 4 0001439222-26-000081 8262
2026-06-23 4 FORM 4 0001439222-26-000079 7963
2026-06-18 S-8 S-8 0001193125-26-275895 333-296899 261102773 33 261739 1 1
2026-06-18 8-K 8-K 5.02,5.07,9.01 0001193125-26-275879 001-36014 261102692 34 154118 1 1
2026-06-16 4 FORM 4 0001439222-26-000077 7335
2026-06-16 4 FORM 4 0001439222-26-000075 7148
2026-05-15 SCHEDULE 13G/A xslSCHEDULE_13G_X02/primary_doc.xml 0001172661-26-002118 005-87570 26983978 34 10597
2026-05-06 SCHEDULE 13G xslSCHEDULE_13G_X02/primary_doc.xml 0000902664-26-002289 005-87570 26948801 34 14999
2026-04-29 SCHEDULE 13G xslSCHEDULE_13G_X02/primary_doc.xml 0002100119-26-000131 005-87570 26917026 34 7413
2026-04-29 10-Q 10-Q 0001439222-26-000073 001-36014 26910950 34 5817733 1 1
2026-04-29 8-K 8-K 2.02,9.01 0001439222-26-000071 001-36014 26910363 34 312660 1 1
2026-04-24 ARS ARS 0001193125-26-177164 001-36014 26893704 34 13707310
2026-04-24 DEFA14A DEFA14A 0001193125-26-177092 001-36014 26893501 34 512396
2026-04-24 DEF 14A DEF 14A 0001193125-26-177086 001-36014 26893455 34 4995838 1 1
2026-04-06 4 FORM 4 0001439222-26-000067 9382
2026-04-06 4 FORM 4 0001439222-26-000065 9541
2026-04-06 4 FORM 4 0001439222-26-000063 9571
2026-04-06 4 FORM 4 0001439222-26-000061 9419
2026-04-06 4 FORM 4 0001439222-26-000059 9406
2026-04-06 4 FORM 4 0001439222-26-000057 15295
2026-04-02 144 xsl144X01/primary_doc.xml 0001439222-26-000055 001-36014 26833508 33 5108
2026-04-02 144 xsl144X01/primary_doc.xml 0001439222-26-000054 001-36014 26833419 33 5054
2026-04-02 144 xsl144X01/primary_doc.xml 0001439222-26-000053 001-36014 26833358 33 5081
2026-04-02 144 xsl144X01/primary_doc.xml 0001439222-26-000052 001-36014 26833257 33 5651
2026-04-02 144 xsl144X01/primary_doc.xml 0001439222-26-000051 001-36014 26833224 33 5057
2026-04-02 144 xsl144X01/primary_doc.xml 0001439222-26-000050 001-36014 26833178 33 5057
2026-03-26 SCHEDULE 13G/A xslSCHEDULE_13G_X02/primary_doc.xml 0000102909-26-000536 005-87570 26797378 34 7179
2026-03-09 4 FORM 4 0001439222-26-000049 8885
2026-03-05 144 xsl144X01/primary_doc.xml 0001439222-26-000047 001-36014 26726527 33 4487
2026-03-05 4 FORM 4 0001439222-26-000046 4628
2026-03-03 4 FORM 4 0001439222-26-000044 24349
2026-03-03 4 FORM 4 0001439222-26-000042 29071
2026-03-03 4 FORM 4 0001439222-26-000040 26311
2026-03-03 4 FORM 4 0001439222-26-000038 29098
2026-03-03 4 FORM 4 0001439222-26-000036 18862
2026-03-03 4 FORM 4 0001439222-26-000034 22247
2026-03-03 4 FORM 4 0001439222-26-000032 7870
2026-03-02 144 xsl144X01/primary_doc.xml 0001439222-26-000030 001-36014 26707679 33 5108
2026-03-02 144 xsl144X01/primary_doc.xml 0001439222-26-000029 001-36014 26707635 33 5056
2026-03-02 144 xsl144X01/primary_doc.xml 0001439222-26-000028 001-36014 26707604 33 5056
2026-03-02 144 xsl144X01/primary_doc.xml 0001439222-26-000027 001-36014 26707560 33 5053
2026-03-02 144 xsl144X01/primary_doc.xml 0001439222-26-000026 001-36014 26707509 33 5650
2026-02-17 SCHEDULE 13G xslSCHEDULE_13G_X01/primary_doc.xml 0001172661-26-001266 005-87570 26645134 34 10440
2026-02-12 S-3ASR S-3ASR 0001193125-26-048780 333-293421 26626479 33 1345053 1 1
2026-02-12 10-K 10-K 0001439222-26-000025 001-36014 26623809 34 20171716 1 1
2026-02-12 8-K 8-K 2.02,9.01 0001439222-26-000023 001-36014 26623268 34 371155 1 1
2026-02-09 SCHEDULE 13G/A xslSCHEDULE_13G_X01/primary_doc.xml 0000908834-26-000066 005-87570 26609756 34 61592
2026-02-09 SCHEDULE 13G xslSCHEDULE_13G_X01/primary_doc.xml 0000093751-26-000018 005-87570 26609482 34 8022
2026-01-12 8-K 8-K 7.01,9.01 0001439222-26-000018 001-36014 26524652 34 4546954 1 1
2026-01-07 4 FORM 4 0001439222-26-000013 8902
2026-01-05 144 xsl144X01/primary_doc.xml 0001439222-26-000011 001-36014 26505873 33 5062
2026-01-02 4 FORM 4 0001439222-26-000010 9244
2026-01-02 4 FORM 4 0001439222-26-000008 15162
2026-01-02 4 FORM 4 0001439222-26-000006 9242
2026-01-02 4 FORM 4 0001439222-26-000004 9281
2026-01-02 4 FORM 4 0001439222-26-000002 9433
2025-12-30 144 xsl144X01/primary_doc.xml 0001439222-25-000126 001-36014 251614515 33 4524
2025-12-30 144 xsl144X01/primary_doc.xml 0001439222-25-000125 001-36014 251614494 33 6228
2025-12-30 144 xsl144X01/primary_doc.xml 0001439222-25-000124 001-36014 251614471 33 4467
2025-12-30 144 xsl144X01/primary_doc.xml 0001439222-25-000122 001-36014 251614415 33 4504
2025-12-30 144 xsl144X01/primary_doc.xml 0001439222-25-000121 001-36014 251614392 33 4472
2025-12-05 SCHEDULE 13G/A xslSCHEDULE_13G_X01/primary_doc.xml 0001104659-25-118951 005-87570 251554056 34 9449
2025-11-14 SCHEDULE 13G/A xslSCHEDULE_13G_X01/primary_doc.xml 0001104659-25-112633 005-87570 251487293 34 12662
2025-11-14 4 FORM 4 0001439222-25-000120 8284
2025-11-13 4 FORM 4 0001439222-25-000118 8894
2025-11-12 144 xsl144X01/primary_doc.xml 0001950047-25-008736 001-36014 251470390 33 6326
2025-11-03 4 FORM 4 0001881190-25-000004 8437
2025-10-30 144 xsl144X01/primary_doc.xml 0001950047-25-008305 001-36014 251436896 33 5491
2025-10-30 10-Q 10-Q 0001439222-25-000116 001-36014 251432640 34 6529920 1 1
2025-10-30 8-K 8-K 2.02,9.01 0001439222-25-000114 001-36014 251432060 34 386002 1 1
2025-10-29 4 FORM 4 0001439222-25-000111 9055
2025-10-27 144 xsl144X01/primary_doc.xml 0001950047-25-008210 001-36014 251420307 33 4809
2025-10-10 4 FORM 4 0001439222-25-000108 8281
2025-10-08 144 xsl144X01/primary_doc.xml 0001950047-25-007829 001-36014 251382331 33 6812
2025-10-02 4 FORM 4 0001439222-25-000106 8281
2025-09-30 4 FORM 4 0001439222-25-000104 8898
2025-09-30 144 xsl144X01/primary_doc.xml 0001950047-25-007588 001-36014 251361179 33 6132
2025-09-26 144 xsl144X01/primary_doc.xml 0001840056-25-000004 001-36014 251350787 33 4468
2025-09-09 4 FORM 4 0001439222-25-000102 4629
2025-08-29 4 FORM 4 0001439222-25-000100 8281
2025-08-28 SCHEDULE 13G xslSCHEDULE_13G_X01/primary_doc.xml 0001104659-25-084792 005-87570 251274012 34 16226
2025-08-27 144 xsl144X01/primary_doc.xml 0001950047-25-006426 001-36014 251265373 33 5449
2025-08-13 4 FORM 4 0001439222-25-000098 6901
2025-08-13 4 FORM 4 0001439222-25-000097 6900
2025-08-12 4 FORM 4 0001439222-25-000093 8889
2025-08-08 144 xsl144X01/primary_doc.xml 0001900772-25-000010 001-36014 251199754 33 5109
2025-08-04 8-K 8-K 7.01 0001439222-25-000090 001-36014 251179279 34 153635 1 1
2025-07-31 10-Q 10-Q 0001439222-25-000089 001-36014 251170062 34 6235605 1 1
2025-07-31 8-K 8-K 2.02,9.01 0001439222-25-000087 001-36014 251169239 34 320105 1 1
2025-07-17 SCHEDULE 13G/A xslSCHEDULE_13G_X01/primary_doc.xml 0002052113-25-002989 005-87570 251132135 34 11079
2025-07-15 4 FORM 4 0001439222-25-000084 8285
2025-07-11 4 FORM 4 0001439222-25-000082 10751
2025-07-10 144 xsl144X01/primary_doc.xml 0001950047-25-004966 001-36014 251116975 33 4764
2025-07-10 4 FORM 4 0001439222-25-000080 7825
2025-07-10 3 FORM 3 0001439222-25-000078 408935
2025-07-09 144 xsl144X01/primary_doc.xml 0001950047-25-004940 001-36014 251114164 33 6182
2025-07-08 8-K 8-K 5.02 0001439222-25-000076 001-36014 251109513 34 148693 1 1
2025-07-07 SCHEDULE 13G xslSCHEDULE_13G_X01/primary_doc.xml 0001104659-25-066212 005-87570 251109288 34 8931
2025-07-03 4 FORM 4 0001439222-25-000073 8858
2025-07-01 144 xsl144X01/primary_doc.xml 0001900772-25-000007 001-36014 251096256 33 4948
2025-06-26 4 FORM 4 0001439222-25-000071 9242
2025-06-26 4 FORM 4 0001439222-25-000069 9240
2025-06-26 4 FORM 4 0001439222-25-000067 9270
2025-06-26 4 FORM 4 0001439222-25-000065 9279
2025-06-26 4 FORM 4 0001439222-25-000063 15155
2025-06-24 144 xsl144X01/primary_doc.xml 0001900772-25-000006 001-36014 251069215 33 4415
2025-06-24 144 xsl144X01/primary_doc.xml 0001900772-25-000005 001-36014 251069159 33 4366
2025-06-24 144 xsl144X01/primary_doc.xml 0001900772-25-000004 001-36014 251069072 33 4358
2025-06-24 144 xsl144X01/primary_doc.xml 0001900772-25-000003 001-36014 251068981 33 4355
2025-06-24 144 xsl144X01/primary_doc.xml 0001900772-25-000002 001-36014 251068918 33 4363
2025-06-23 4 FORM 4 0001439222-25-000061 11429
2025-06-23 4 FORM 4 0001439222-25-000059 11436
2025-06-23 4 FORM 4 0001439222-25-000057 12164
2025-06-23 4 FORM 4 0001439222-25-000055 11494
2025-06-23 4 FORM 4 0001439222-25-000053 11434
2025-06-23 4 FORM 4 0001439222-25-000051 11625
2025-06-23 4 FORM 4 0001439222-25-000049 11401
2025-06-23 4 FORM 4 0001439222-25-000047 11412
2025-06-18 S-8 S-8 0001193125-25-142763 333-288151 251057489 33 292463 1 1
2025-06-18 8-K 8-K 5.02,5.07,9.01 0001193125-25-142745 001-36014 251057369 34 151877 1 1
2025-06-17 4 FORM 4 0001439222-25-000045 7014
2025-06-17 4 FORM 4 0001439222-25-000043 7201
2025-06-13 SCHEDULE 13G/A xslSCHEDULE_13G_X01/primary_doc.xml 0001104659-25-059295 005-87570 251045875 34 9461
2025-05-01 10-Q 10-Q 0001439222-25-000036 001-36014 25900288 34 5813804 1 1
2025-05-01 8-K 8-K 2.02,9.01 0001439222-25-000034 001-36014 25899206 34 315738 1 1
2025-04-25 ARS ARS 0001193125-25-096748 001-36014 25873946 34 1844479
2025-04-25 DEFA14A DEFA14A 0001193125-25-096729 001-36014 25873785 34 193102
2025-04-25 DEF 14A DEF 14A 0001193125-25-096719 001-36014 25873726 34 4268493 1 1
2025-04-10 4 FORM 4 0001439222-25-000029 8879
2025-04-08 144 xsl144X01/primary_doc.xml 0001957180-25-000014 001-36014 25823161 33 4368
2025-03-07 4 FORM 4 0001439222-25-000027 7898
2025-03-07 3 FORM 3 0001439222-25-000025 440703
2025-03-05 S-8 S-8 0001193125-25-047359 333-285585 25712550 33 445190 1 1
2025-03-04 4 FORM 4 0001439222-25-000021 26486
2025-03-04 4 FORM 4 0001439222-25-000019 21038
2025-03-04 4 FORM 4 0001439222-25-000017 13383
2025-03-04 4 FORM 4 0001439222-25-000015 18867
2025-03-04 4 FORM 4 0001439222-25-000013 24482
2025-03-04 4 FORM 4 0001439222-25-000011 24437
2025-03-03 144 xsl144X01/primary_doc.xml 0001957180-25-000013 001-36014 25698882 33 4960
2025-03-03 144 xsl144X01/primary_doc.xml 0001957180-25-000012 001-36014 25698856 33 4378
2025-03-03 144 xsl144X01/primary_doc.xml 0001957180-25-000010 001-36014 25698820 33 4426
2025-03-03 144 xsl144X01/primary_doc.xml 0001957180-25-000009 001-36014 25698781 33 4368
2025-03-03 144 xsl144X01/primary_doc.xml 0001957180-25-000008 001-36014 25698758 33 4370
2025-02-14 SCHEDULE 13G/A xslSCHEDULE_13G_X01/primary_doc.xml 0001104659-25-013933 005-87570 25626904 34 9078
2025-02-13 10-K 10-K 0001439222-25-000009 001-36014 25617619 34 11585055 1 1
2025-02-13 8-K 8-K 2.02,9.01 0001439222-25-000007 001-36014 25617088 34 335669 1 1
2025-02-13 8-K 8-K 5.02 0001193125-25-025524 001-36014 25616955 34 139217 1 1
2025-02-05 4 FORM 4 0001439222-25-000004 8881
2025-02-04 SCHEDULE 13G/A xslSCHEDULE_13G_X01/primary_doc.xml 0000908834-25-000038 005-87570 25586327 34 57955 1 1
2025-01-13 8-K 8-K 7.01,9.01 0001193125-25-004943 001-36014 25524747 34 3936839 1 1
2025-01-07 4 FORM 4 0001439222-25-000002 8912
2025-01-06 8-K 8-K 7.01 0001193125-25-001809 001-36014 25508991 34 143856 1 1
2025-01-03 144 xsl144X01/primary_doc.xml 0001957180-25-000002 001-36014 25506685 33 4372
2024-12-13 4 FORM 4 0001439222-24-000146 8291
2024-11-14 SC 13G/A armistice-agio093024a2.htm 0001172661-24-005116 005-87570 241461187 34 90770
2024-11-13 4 FORM 4 0001439222-24-000144 4804
2024-11-12 4 FORM 4 0001439222-24-000142 19741
2024-11-12 4 FORM 4 0001439222-24-000140 7234
2024-11-08 144 xsl144X01/primary_doc.xml 0001950047-24-008290 001-36014 241440861 33 5485
2024-11-08 SC 13G/A agios_13ga.htm 0000908834-24-000295 005-87570 241439992 34 432498
2024-11-07 144 xsl144X01/primary_doc.xml 0001950047-24-008262 001-36014 241436767 33 4799
2024-11-07 144 xsl144X01/primary_doc.xml 0001950047-24-008213 001-36014 241435572 33 8944
2024-10-31 10-Q 10-Q 0001439222-24-000138 001-36014 241412729 34 6496656 1 1
2024-10-31 8-K 8-K 2.02,9.01 0001439222-24-000136 001-36014 241412366 34 332961 1 1
2024-09-30 4 FORM 4 0001439222-24-000129 9090
2024-08-13 4 FORM 4 0001439222-24-000127 6910
2024-08-13 4 FORM 4 0001439222-24-000125 6893
2024-08-12 4 FORM 4 0001439222-24-000123 8903
2024-08-08 144 xsl144X01/primary_doc.xml 0001578200-24-000005 001-36014 241188328 33 5049
2024-08-01 10-Q 10-Q 0001439222-24-000121 001-36014 241164807 34 6347203 1 1
2024-08-01 8-K 8-K 2.02,9.01 0001439222-24-000117 001-36014 241164173 34 335493 1 1
2024-07-03 4 FORM 4 0001439222-24-000111 8867
2024-07-01 144 xsl144X01/primary_doc.xml 0001546216-24-000008 001-36014 241090689 33 4406
2024-06-24 UPLOAD filename1.pdf 0000000000-24-007133 001-36014 39795
2024-06-24 4 FORM 4 0001439222-24-000109 7856
2024-06-24 4 FORM 4 0001439222-24-000108 7775
2024-06-24 4 FORM 4 0001439222-24-000107 7802
2024-06-24 4 FORM 4 0001439222-24-000106 7792
2024-06-24 4 FORM 4 0001439222-24-000105 7820
2024-06-24 4 FORM 4 0001439222-24-000104 7797
2024-06-24 4 FORM 4 0001439222-24-000103 7798
2024-06-24 4 FORM 4 0001439222-24-000102 7854
2024-06-24 4 FORM 4 0001439222-24-000101 7764
2024-06-20 8-K 8-K 5.07 0001193125-24-164555 001-36014 241057361 34 152046 1 1
2024-06-17 4 FORM 4 0001439222-24-000091 9217
2024-06-17 4 FORM 4 0001439222-24-000089 7031
2024-06-17 4 FORM 4 0001439222-24-000087 8801
2024-06-17 4 FORM 4 0001439222-24-000085 6965
2024-06-17 4 FORM 4 0001439222-24-000083 6948
2024-06-17 4 FORM 4 0001439222-24-000081 6971
2024-06-17 4 FORM 4 0001439222-24-000079 6938
2024-06-17 4 FORM 4 0001439222-24-000077 7017
2024-06-17 4 FORM 4 0001439222-24-000075 7021
2024-06-11 CORRESP filename1.htm 0001193125-24-159247 38858
2024-06-07 4 FORM 4 0001439222-24-000073 9315
2024-06-05 144 xsl144X01/primary_doc.xml 0001546216-24-000006 001-36014 241023551 33 5048
2024-06-05 4 FORM 4 0001439222-24-000071 4637
2024-05-30 UPLOAD filename1.pdf 0000000000-24-006246 001-36014 47126
2024-05-28 8-K 8-K 1.01,8.01,9.01 0001193125-24-147583 001-36014 24986255 34 169078 1 1
2024-05-02 10-Q 10-Q 0001439222-24-000069 001-36014 24905690 34 5505806 1 1
2024-05-02 8-K 8-K 2.02,9.01 0001439222-24-000067 001-36014 24905208 34 295292 1 1
2024-04-26 ARS ARS 0001193125-24-117998 001-36014 24883680 34 2203989
2024-04-26 DEFA14A DEFA14A 0001193125-24-117966 001-36014 24883512 34 435587
2024-04-26 DEF 14A DEF 14A 0001193125-24-117951 001-36014 24883432 34 4297031 1 1
2024-04-10 4 FORM 4 0001439222-24-000063 8890
2024-03-11 4 FORM 4 0001439222-24-000061 5274
2024-03-07 4 FORM 4 0001439222-24-000058 7094
2024-03-07 4 FORM 4 0001439222-24-000056 4636
2024-03-07 144 xsl144X01/primary_doc.xml 0001950047-24-002026 001-36014 24730522 33 6776
2024-03-06 144 xsl144X01/primary_doc.xml 0001950047-24-001982 001-36014 24727424 33 6096
2024-03-05 144 xsl144X01/primary_doc.xml 0001950047-24-001926 001-36014 24723460 33 5311
2024-03-05 4 FORM 4 0001439222-24-000054 18996
2024-03-05 4 FORM 4 0001439222-24-000052 13586
2024-03-05 4 FORM 4 0001439222-24-000050 16772
2024-03-05 4 FORM 4 0001439222-24-000048 13375
2024-03-05 4 FORM 4 0001439222-24-000046 18998
2024-03-05 4 FORM 4 0001439222-24-000044 7890
2024-03-01 144 xsl144X01/primary_doc.xml 0001546216-24-000004 001-36014 24710315 33 5630
2024-03-01 144 xsl144X01/primary_doc.xml 0001546216-24-000003 001-36014 24710289 33 6160
2024-03-01 144 xsl144X01/primary_doc.xml 0001546216-24-000002 001-36014 24710273 33 6159
2024-03-01 144 xsl144X01/primary_doc.xml 0001546216-24-000001 001-36014 24710202 33 4998
2024-02-29 4 FORM 4 0001439222-24-000042 15711
2024-02-27 144 xsl144X01/primary_doc.xml 0001950047-24-001483 001-36014 24688047 33 6105
2024-02-27 4 FORM 4 0001439222-24-000040 15715
2024-02-26 144 xsl144X01/primary_doc.xml 0001578200-24-000003 001-36014 24681591 33 7055
2024-02-22 4 FORM 4 0001439222-24-000037 4635
2024-02-15 10-K 10-K 0001439222-24-000035 001-36014 24642625 34 11141146 1 1
2024-02-15 8-K 8-K 2.02,9.01 0001439222-24-000032 001-36014 24642024 34 320281 1 1
2024-02-14 4 FORM 4 0001439222-24-000030 8876
2024-02-14 4 FORM 4 0001439222-24-000028 8878
2024-02-14 4 FORM 4 0001439222-24-000026 8920
2024-02-14 SC 13G/A armistice-agio123123a1.htm 0001172661-24-001214 005-87570 24636062 34 90771
2024-02-14 SC 13G/A rocksprings-agio123123a1.htm 0001172661-24-001204 005-87570 24635901 34 89675
2024-02-13 SC 13G/A SC 13G/A 0001193125-24-032786 005-87570 24622464 34 49538
2024-02-12 SC 13G/A SCHEDULE 13G/A 0001104659-24-013960 005-87570 24618227 34 13115
2024-02-12 SC 13G/A SCHEDULE 13G/A 0001104659-24-013917 005-87570 24618056 34 13115
2024-02-08 SC 13G/A agio_13ga.htm 0000908834-24-000046 005-87570 24607740 34 434759
2024-01-25 SC 13G/A us00847x1046_012524.txt 0001086364-24-003298 005-87570 24561078 34 13641
2024-01-24 4 FORM 4 0001439222-24-000022 9067
2024-01-24 4 FORM 4 0001439222-24-000020 9065
2024-01-24 4 FORM 4 0001439222-24-000018 9119
2024-01-24 4 FORM 4 0001439222-24-000016 9086
2024-01-24 4 FORM 4 0001439222-24-000014 9318
2024-01-24 4 FORM 4 0001439222-24-000012 9108
2024-01-22 SC 13G/A Agios_Pharmaceuticals_Inc.txt 0000093751-24-000059 005-87570 24547825 34 8572
2024-01-09 4 FORM 4 0001439222-24-000010 9330
2024-01-09 4 FORM 4 0001439222-24-000008 9092
2024-01-09 4 FORM 4 0001439222-24-000006 9235
2024-01-09 4 FORM 4 0001439222-24-000004 9233
2024-01-08 8-K FORM 8-K 7.01,9.01 0001193125-24-003920 001-36014 24518373 34 2974860 1 1
2024-01-05 4 FORM 4 0001439222-24-000002 8912
2023-11-09 SC 13G agio_13g.htm 0000908834-23-000146 005-87570 231393799 34 445074
2023-11-09 SC 13G/A SEC SCHEDULE 13G 0000902219-23-000049 005-87570 231391558 34 32951
2023-11-02 10-Q 10-Q 0001439222-23-000140 001-36014 231370382 34 5985536 1 1
2023-11-02 8-K 8-K 2.02,9.01 0001439222-23-000138 001-36014 231370006 34 313178 1 1
2023-09-28 4 FORM 4 0001439222-23-000133 8996
2023-08-21 4 FORM 4 0001439222-23-000131 4967
2023-08-15 4 FORM 4 0001439222-23-000129 6828
2023-08-15 4 FORM 4 0001439222-23-000127 6811
2023-08-11 4 FORM 4 0001439222-23-000125 9205
2023-08-10 4 FORM 4 0001439222-23-000123 8470
2023-08-09 4 FORM 4 0001439222-23-000121 5015
2023-08-03 10-Q 10-Q 0001439222-23-000119 001-36014 231138344 34 6075071 1 1
2023-08-03 8-K 8-K 2.02,9.01 0001439222-23-000117 001-36014 231137939 34 319867 1 1
2023-08-02 4 FORM 4 0001439222-23-000113 8548
2023-07-06 4 FORM 4 0001439222-23-000111 5511
2023-06-30 4 FORM 4 0001439222-23-000109 8789
2023-06-30 4 FORM 4 0001439222-23-000107 8809
2023-06-30 4 FORM 4 0001439222-23-000105 8787
2023-06-30 4 FORM 4 0001439222-23-000103 8854
2023-06-30 4 FORM 4 0001439222-23-000101 8829
2023-06-30 4 FORM 4 0001439222-23-000099 8824
2023-06-23 4 FORM 4 0001439222-23-000097 7871
2023-06-23 4 FORM 4 0001439222-23-000095 6893
2023-06-23 4 FORM 4 0001439222-23-000093 6860
2023-06-23 4 FORM 4 0001439222-23-000091 8723
2023-06-15 4 FORM 4 0001439222-23-000089 7829
2023-06-15 4 FORM 4 0001439222-23-000087 7833
2023-06-15 4 FORM 4 0001439222-23-000085 7774
2023-06-15 4 FORM 4 0001439222-23-000083 7682
2023-06-15 4 FORM 4 0001439222-23-000081 7772
2023-06-15 4 FORM 4 0001439222-23-000079 7710
2023-06-15 4 FORM 4 0001439222-23-000077 7715
2023-06-15 4 FORM 4 0001439222-23-000075 7693
2023-06-15 4 FORM 4 0001439222-23-000073 7738
2023-06-15 3 FORM 3 0001439222-23-000071 407425
2023-06-15 3 FORM 3 0001439222-23-000069 430009
2023-06-14 8-K 8-K 5.02,5.07,9.01 0001193125-23-166855 001-36014 231014136 34 159985 1 1
2023-06-13 S-8 S-8 0001193125-23-166035 333-272615 231011351 33 170742
2023-05-25 8-K 8-K 5.02 0001193125-23-154190 001-36014 23960360 34 146535 1 1
2023-05-04 10-Q 10-Q 0001439222-23-000065 001-36014 23886903 34 5764935 1 1
2023-05-04 8-K 8-K 2.02,9.01 0001439222-23-000063 001-36014 23886385 34 325088 1 1
2023-04-26 ARS ARS 0001193125-23-118511 001-36014 23849768 34 11408488
2023-04-26 DEFA14A DEFA14A 0001193125-23-118499 001-36014 23849711 34 41158
2023-04-26 DEF 14A DEF 14A 0001193125-23-118490 001-36014 23849655 34 6020899 1 1
2023-04-19 8-K 8-K 5.02 0001193125-23-105679 001-36014 23828459 34 146402 1 1
2023-04-12 4 FORM 4 0001439222-23-000059 8299
2023-04-10 SC 13G/A SEC SCHEDULE 13G 0000902219-23-000019 005-87570 23809803 34 37280
2023-04-05 4 FORM 4 0001439222-23-000058 11211
2023-03-29 4 FORM 4 0001439222-23-000056 11216
2023-03-15 4 FORM 4 0001439222-23-000055 13077
2023-03-07 4 FORM 4 0001439222-23-000053 4737
2023-03-03 8-K 8-K 5.03,9.01 0001193125-23-060031 001-36014 23704042 34 308142 1 1
2023-03-03 4 FORM 4 0001439222-23-000051 10669
2023-03-03 4 FORM 4 0001439222-23-000050 7824
2023-03-03 4 FORM 4 0001439222-23-000049 12731
2023-03-03 4 FORM 4 0001439222-23-000048 7810
2023-03-03 4 FORM 4 0001439222-23-000047 12890
2023-03-01 4 FORM 4 0001439222-23-000041 11222
2023-02-23 S-8 S-8 0001193125-23-046628 333-269951 23659986 33 71881
2023-02-23 S-3ASR S-3ASR 0001193125-23-046608 333-269949 23659918 33 1229787
2023-02-23 10-K 10-K 0001439222-23-000039 001-36014 23657200 34 11447600 1 1
2023-02-23 8-K 8-K 2.02,9.01 0001439222-23-000037 001-36014 23655877 34 343541 1 1
2023-02-21 4 FORM 4 0001439222-23-000028 4737
2023-02-16 4 FORM 4 0001439222-23-000026 9826
2023-02-16 4 FORM 4 0001439222-23-000025 8253
2023-02-16 4 FORM 4 0001439222-23-000024 8270
2023-02-15 4 FORM 4 0001439222-23-000020 11222
2023-02-14 SC 13G/A SC 13G/A 0001193125-23-039104 005-87570 23629232 34 52000
2023-02-14 4 FORM 4 0001439222-23-000018 8256
2023-02-14 4 FORM 4 0001439222-23-000017 8254
2023-02-14 4 FORM 4 0001439222-23-000016 10644
2023-02-14 SC 13G rocksprings-agio123122.htm 0001172661-23-001245 005-87570 23627498 34 89315
2023-02-14 SC 13G/A agio13gadec22.txt 0000080255-23-002609 005-87570 34 7106
2023-02-14 SC 13G armistice-agio123122.htm 0001172661-23-001035 005-87570 23625084 34 90658
2023-02-09 SC 13G/A SCHEDULE 13G/A 0001104659-23-015222 005-87570 23602172 34 13033
2023-02-08 SC 13G/A Agios_Pharmaceuticals_Inc.txt 0000093751-23-000336 005-87570 23597321 34 8490
2023-02-06 SC 13G/A SEC SCHEDULE 13G 0000846087-23-000066 005-87570 23590017 34 37293
2023-02-03 5 FORM 5 0001439222-23-000012 4745
2023-02-01 4 FORM 4 0001439222-23-000010 13077
2023-01-25 SC 13G/A us00847x1046_012523.txt 0001306550-23-003493 005-87570 23550537 34 13494
2023-01-19 4 FORM 4 0001439222-23-000008 13078
2023-01-18 4 FORM 4 0001439222-23-000006 5545
2023-01-09 8-K 8-K 7.01,9.01 0001193125-23-004143 001-36014 23516553 34 13508696 1 1
2023-01-05 4 FORM 4 0001439222-23-000004 7831
2023-01-05 3 FORM 3 0001439222-23-000002 7479
2023-01-03 S-8 S-8 0001193125-23-000881 333-269108 23503315 33 269921
2022-12-28 4 FORM 4 0001439222-22-000105 8378
2022-12-28 4 FORM 4 0001439222-22-000104 8215
2022-12-16 8-K 8-K 5.02,9.01 0001193125-22-307300 001-36014 221467896 34 142569 1 1
2022-12-06 4 FORM 4 0001439222-22-000101 8406
2022-12-06 8-K 8-K 5.02,9.01 0001193125-22-298895 001-36014 221446707 34 175865 1 1
2022-11-03 10-Q 10-Q 0001439222-22-000099 001-36014 221356637 34 6802675 1 1
2022-11-03 8-K 8-K 2.02,9.01 0001439222-22-000098 001-36014 221356133 34 349541 1 1
2022-10-27 8-K 8-K 1.01,8.01,9.01 0001193125-22-270979 001-36014 221337559 34 181015 1 1
2022-10-18 4 FORM 4 0001439222-22-000091 8372
2022-10-07 8-K 8-K 5.02,9.01 0001193125-22-259591 001-36014 221300809 34 249072 1 1
2022-10-06 SC 13G/A FILING AGIOS PHARMACEUTICALS, INC. 0000019617-22-000474 005-87570 34 89886
2022-09-28 4 FORM 4 0001439222-22-000089 7850
2022-09-28 3 FORM 3 0001439222-22-000087 7473
2022-09-26 S-8 S-8 0001193125-22-251376 333-267624 221266650 33 258507
2022-09-19 8-K 8-K 5.02,9.01 0001193125-22-246740 001-36014 221249360 34 178064 1 1
2022-09-12 SC 13G/A filing.txt 0000315066-22-001754 005-87570 221237946 34 8107
2022-09-07 8-K 8-K 5.02 0001193125-22-239454 001-36014 221229900 34 138375 1 1
2022-08-15 4 FORM 4 0001439222-22-000085 7763
2022-08-15 4 FORM 4 0001439222-22-000084 7780
2022-08-15 3 FORM 3 0001439222-22-000083 7405
2022-08-15 3 FORM 3 0001439222-22-000081 7422
2022-08-15 8-K 8-K 5.02 0001193125-22-221224 001-36014 221165947 34 143300 1 1
2022-08-09 3/A FORM 3/A 0001439222-22-000076 7523
2022-08-09 4 FORM 4 0001439222-22-000074 7816
2022-08-09 3 FORM 3 0001439222-22-000072 3167
2022-08-08 S-8 S-8 0001193125-22-215092 333-266675 221145609 33 93908
2022-08-04 10-Q 10-Q 0001439222-22-000070 001-36014 221135159 34 6945415 1 1
2022-08-04 8-K 8-K 2.02,9.01 0001193125-22-211808 001-36014 221134652 34 228758 1 1
2022-07-12 8-K 8-K 5.02,9.01 0001193125-22-192006 001-36014 221079306 34 189265 1 1
2022-06-23 4 FORM 4 0001439222-22-000066 7784

Latest XBRL company facts

One latest value per concept from companyfacts (400 concepts). Full history stays in the JSON.

TaxonomyTagLabelUnitValueStartEndFYFPFormFiledAccn
dei EntityCommonStockSharesOutstanding Entity Common Stock, Shares Outstanding shares 59.81M 2026-10-30 2026 Q3 10-Q 2026-11-05 0001439222-26-000131
dei EntityPublicFloat Entity Public Float USD 1.91B 2025-06-30 2025 FY 10-K 2026-02-12 0001439222-26-000025
ecd CoSelectedMeasureAmt CoSelectedMeasureAmt USD 54.03M 2025-01-01 2025-12-31 DEF 14A 2026-04-24 0001193125-26-177086
ecd NonPeoNeoAvgCompActuallyPaidAmt NonPeoNeoAvgCompActuallyPaidAmt USD 2.24M 2025-01-01 2025-12-31 DEF 14A 2026-04-24 0001193125-26-177086
ecd NonPeoNeoAvgTotalCompAmt NonPeoNeoAvgTotalCompAmt USD 2.44M 2025-01-01 2025-12-31 DEF 14A 2026-04-24 0001193125-26-177086
ecd PeerGroupTotalShareholderRtnAmt PeerGroupTotalShareholderRtnAmt USD 119.92 2025-01-01 2025-12-31 DEF 14A 2026-04-24 0001193125-26-177086
ecd TotalShareholderRtnAmt TotalShareholderRtnAmt USD 62.82 2025-01-01 2025-12-31 DEF 14A 2026-04-24 0001193125-26-177086
us-gaap AccountsAndOtherReceivablesNetCurrent Accounts and Other Receivables, Net, Current USD 0 2022-12-31 2022 FY 10-K 2023-02-23 0001439222-23-000039
us-gaap AccountsPayableCurrent Accounts Payable, Current USD 19.93M 2026-09-30 2026 Q3 10-Q 2026-11-05 0001439222-26-000131
us-gaap AccretionAmortizationOfDiscountsAndPremiumsInvestments Accretion (Amortization) of Discounts and Premiums, Investments USD 3.19M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-05 0001439222-26-000131
us-gaap AccruedIncomeTaxesCurrent Accrued Income Taxes, Current USD 1.46M 2013-12-31 2014 Q1 10-Q 2014-05-09 0001193125-14-192411
us-gaap AccruedLiabilitiesCurrent Accrued Liabilities, Current USD 38.01M 2026-09-30 2026 Q3 10-Q 2026-11-05 0001439222-26-000131
us-gaap AccruedProfessionalFeesCurrent Accrued Professional Fees, Current USD 3.55M 2026-09-30 2026 Q3 10-Q 2026-11-05 0001439222-26-000131
us-gaap AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment Accumulated Depreciation, Depletion and Amortization, Property, Plant, and Equipment USD 60.12M 2025-12-31 2025 FY 10-K 2026-02-12 0001439222-26-000025
us-gaap AccumulatedOtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax AOCI, Debt Securities, Available-for-sale, Adjustment, after Tax USD -4.29M 2026-09-30 2026 Q3 10-Q 2026-11-05 0001439222-26-000131
us-gaap AccumulatedOtherComprehensiveIncomeLossNetOfTax Accumulated Other Comprehensive Income (Loss), Net of Tax USD 25,000 2013-09-30 2013 Q3 10-Q 2013-11-07 0001193125-13-433119
us-gaap AdditionalPaidInCapitalCommonStock Additional Paid in Capital, Common Stock USD 2.61B 2026-09-30 2026 Q3 10-Q 2026-11-05 0001439222-26-000131
us-gaap AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue APIC, Share-based Payment Arrangement, Increase for Cost Recognition USD 16.67M 2026-07-01 2026-09-30 2026 Q3 10-Q 2026-11-05 0001439222-26-000131
us-gaap AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationRestrictedStockUnitsRequisiteServicePeriodRecognition APIC, Share-based Payment Arrangement, Restricted Stock Unit, Increase for Cost Recognition USD 6,000 2015-01-01 2015-12-31 2017 FY 10-K 2018-02-14 0001439222-18-000004
us-gaap AdjustmentsToAdditionalPaidInCapitalStockIssuedIssuanceCosts Adjustments to Additional Paid in Capital, Stock Issued, Issuance Costs USD 900,000 2014-01-01 2014-12-31 2016 FY 10-K 2017-02-16 0001193125-17-046795
us-gaap AllocatedShareBasedCompensationExpense Share-based Payment Arrangement, Expense USD 48.15M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-05 0001439222-26-000131
us-gaap AllowanceForDoubtfulAccountsPremiumsAndOtherReceivables Allowance for Doubtful Accounts, Premiums and Other Receivables USD 0 2017-12-31 2017 FY 10-K 2018-02-14 0001439222-18-000004
us-gaap AllowanceForDoubtfulAccountsReceivableCurrent Accounts Receivable, Allowance for Credit Loss, Current USD 518,000 2026-09-30 2026 Q3 10-Q 2026-11-05 0001439222-26-000131
us-gaap AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount shares 8.81M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-05 0001439222-26-000131
us-gaap Assets Assets USD 1.06B 2026-09-30 2026 Q3 10-Q 2026-11-05 0001439222-26-000131
us-gaap AssetsCurrent Assets, Current USD 752.10M 2026-09-30 2026 Q3 10-Q 2026-11-05 0001439222-26-000131
us-gaap AssetsFairValueDisclosure Assets, Fair Value Disclosure USD 831.24M 2026-09-30 2026 Q3 10-Q 2026-11-05 0001439222-26-000131
us-gaap AssetsOfDisposalGroupIncludingDiscontinuedOperationCurrent Disposal Group, Including Discontinued Operation, Assets, Current USD 0 2021-12-31 2021 FY 10-K 2022-02-24 0001439222-22-000024
us-gaap AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax Debt Securities, Available-for-sale, Accumulated Gross Unrealized Gain, before Tax USD 63,000 2026-09-30 2026 Q3 10-Q 2026-11-05 0001439222-26-000131
us-gaap AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax Debt Securities, Available-for-sale, Accumulated Gross Unrealized Loss, before Tax USD 4.35M 2026-09-30 2026 Q3 10-Q 2026-11-05 0001439222-26-000131
us-gaap AvailableForSaleDebtSecuritiesAmortizedCostBasis Debt Securities, Available-for-sale, Amortized Cost USD 782.76M 2026-09-30 2026 Q3 10-Q 2026-11-05 0001439222-26-000131
us-gaap AvailableForSaleSecurities Available-for-sale Securities USD 508.99M 2017-09-30 2017 Q3 10-Q 2017-11-01 0001439222-17-000009
us-gaap AvailableForSaleSecuritiesAmortizedCost Available-for-sale Securities, Amortized Cost Basis USD 509.51M 2017-09-30 2017 Q3 10-Q 2017-11-01 0001439222-17-000009
us-gaap AvailableForSaleSecuritiesContinuousUnrealizedLossPositionFairValue Available-for-sale Securities, Continuous Unrealized Loss Position, Fair Value USD 224.00M 2020-03-31 2020 Q1 10-Q 2020-04-30 0001439222-20-000039
us-gaap AvailableForSaleSecuritiesContinuousUnrealizedLossPositionLessThanTwelveMonthsFairValue Available-for-sale Securities, Continuous Unrealized Loss Position, Less than Twelve Months, Fair Value USD 143.40M 2016-09-30 2016 Q3 10-Q 2016-11-03 0001193125-16-758835
us-gaap AvailableForSaleSecuritiesCurrent Available-for-sale Securities, Current USD 370.19M 2019-09-30 2019 Q3 10-Q 2019-10-31 0001439222-19-000021
us-gaap AvailableForSaleSecuritiesDebtSecurities Debt Securities, Available-for-sale USD 778.47M 2026-09-30 2026 Q3 10-Q 2026-11-05 0001439222-26-000131
us-gaap AvailableForSaleSecuritiesDebtSecuritiesCurrent Debt Securities, Available-for-sale, Current USD 501.46M 2026-09-30 2026 Q3 10-Q 2026-11-05 0001439222-26-000131
us-gaap AvailableForSaleSecuritiesDebtSecuritiesNoncurrent Debt Securities, Available-for-sale, Noncurrent USD 277.01M 2026-09-30 2026 Q3 10-Q 2026-11-05 0001439222-26-000131
us-gaap AvailableForSaleSecuritiesGrossRealizedGainLossNet Available-for-sale Securities, Gross Realized Gain (Loss) USD 0 2017-01-01 2017-03-31 2017 Q1 10-Q 2017-05-04 0001193125-17-157874
us-gaap AvailableforsaleSecuritiesInUnrealizedLossPositionsQualitativeDisclosureNumberOfPositions1 Available-for-sale, Securities in Unrealized Loss Positions, Qualitative Disclosure, Number of Positions Securities 0 2014-09-30 2014 Q3 10-Q 2014-11-07 0001193125-14-403316
us-gaap AvailableforsaleSecuritiesInUnrealizedLossPositionsQualitativeDisclosureNumberOfPositionsGreaterThanOrEqualToOneYear Available-for-sale, Securities in Unrealized Loss Positions, Qualitative Disclosure, Number of Positions, Greater than or Equal to One Year security 92 2020-03-31 2020 Q1 10-Q 2020-04-30 0001439222-20-000039
us-gaap AvailableForSaleSecuritiesInUnrealizedLossPositionsQualitativeDisclosureNumberOfPositionsLessThanOneYear Available-for-sale, Securities in Unrealized Loss Positions, Qualitative Disclosure, Number of Positions, Less than One Year Securities 62 2016-09-30 2016 Q3 10-Q 2016-11-03 0001193125-16-758835
us-gaap AvailableForSaleSecuritiesNoncurrent Available-for-sale Securities, Noncurrent USD 88.58M 2019-09-30 2019 Q3 10-Q 2019-10-31 0001439222-19-000021
us-gaap CapitalExpendituresIncurredButNotYetPaid Capital Expenditures Incurred but Not yet Paid USD 873,000 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-05 0001439222-26-000131
us-gaap CashAndCashEquivalentsAtCarryingValue Cash and Cash Equivalents, at Carrying Value USD 128.55M 2026-09-30 2026 Q3 10-Q 2026-11-05 0001439222-26-000131
us-gaap CashAndCashEquivalentsFairValueDisclosure Cash and Cash Equivalents, Fair Value Disclosure USD 52.77M 2026-09-30 2026 Q3 10-Q 2026-11-05 0001439222-26-000131
us-gaap CashAndCashEquivalentsPeriodIncreaseDecrease Cash and Cash Equivalents, Period Increase (Decrease) USD -32.22M 2018-01-01 2018-12-31 2018 FY 10-K 2019-02-14 0001439222-19-000004
us-gaap CashCashEquivalentsAndShortTermInvestments Cash, Cash Equivalents, and Short-term Investments USD 907.00M 2026-09-30 2026 Q3 10-Q 2026-11-05 0001439222-26-000131
us-gaap CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents USD 128.55M 2026-09-30 2026 Q3 10-Q 2026-11-05 0001439222-26-000131
us-gaap CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect USD 39.42M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-05 0001439222-26-000131
us-gaap CashProvidedByUsedInFinancingActivitiesDiscontinuedOperations Cash Provided by (Used in) Financing Activities, Discontinued Operations USD 0 2022-01-01 2022-12-31 2022 FY 10-K 2023-02-23 0001439222-23-000039
us-gaap CashProvidedByUsedInInvestingActivitiesDiscontinuedOperations Cash Provided by (Used in) Investing Activities, Discontinued Operations USD 0 2023-01-01 2023-12-31 2023 FY 10-K 2024-02-15 0001439222-24-000035
us-gaap CashProvidedByUsedInOperatingActivitiesDiscontinuedOperations Cash Provided by (Used in) Operating Activities, Discontinued Operations USD 0 2023-01-01 2023-12-31 2023 FY 10-K 2024-02-15 0001439222-24-000035
us-gaap CommonStockCapitalSharesReservedForFutureIssuance Common Stock, Capital Shares Reserved for Future Issuance shares 5.99M 2013-12-31 2013 FY 10-K 2014-03-18 0001193125-14-104521
us-gaap CommonStockParOrStatedValuePerShare Common Stock, Par or Stated Value Per Share USD/shares 0.001 2026-09-30 2026 Q3 10-Q 2026-11-05 0001439222-26-000131
us-gaap CommonStockSharesAuthorized Common Stock, Shares Authorized shares 125.00M 2026-09-30 2026 Q3 10-Q 2026-11-05 0001439222-26-000131
us-gaap CommonStockSharesIssued Common Stock, Shares, Issued shares 76.00M 2026-09-30 2026 Q3 10-Q 2026-11-05 0001439222-26-000131
us-gaap CommonStockSharesOutstanding Common Stock, Shares, Outstanding shares 59.78M 2026-09-30 2026 Q3 10-Q 2026-11-05 0001439222-26-000131
us-gaap CommonStockValue Common Stock, Value, Issued USD 71,000 2022-06-30 2022 Q2 10-Q 2022-08-04 0001439222-22-000070
us-gaap CommonStockValueOutstanding Common Stock, Value, Outstanding USD 76,000 2026-09-30 2026 Q3 10-Q 2026-11-05 0001439222-26-000131
us-gaap ComprehensiveIncomeNetOfTax Comprehensive Income (Loss), Net of Tax, Attributable to Parent USD -271.34M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-05 0001439222-26-000131
us-gaap ContractsReceivableClaimsAndUncertainAmounts Contracts Receivable, Claims and Uncertain Amounts USD 7.90M 2016-06-30 2016 Q2 10-Q 2016-08-08 0001193125-16-675231
us-gaap ContractsRevenue Contracts Revenue (Deprecated 2018-01-31) USD 16.82M 2014-01-01 2014-06-30 2014 Q2 10-Q 2014-08-07 0001193125-14-300949
us-gaap ContractWithCustomerAssetNet Contract with Customer, Asset, after Allowance for Credit Loss USD 32.90M 2026-09-30 2026 Q3 10-Q 2026-11-05 0001439222-26-000131
us-gaap ContractWithCustomerAssetNetCurrent Contract with Customer, Asset, after Allowance for Credit Loss, Current USD 7.64M 2026-09-30 2026 Q3 10-Q 2026-11-05 0001439222-26-000131
us-gaap ContractWithCustomerLiability Contract with Customer, Liability USD 0 2020-12-31 2020 FY 10-K 2021-02-25 0001439222-21-000029
us-gaap ContractWithCustomerLiabilityCurrent Contract with Customer, Liability, Current USD 2.50M 2022-03-31 2022 Q1 10-Q 2022-05-05 0001439222-22-000040
us-gaap ContractWithCustomerLiabilityNoncurrent Contract with Customer, Liability, Noncurrent USD 0 2020-12-31 2020 FY 10-K 2021-02-25 0001439222-21-000029
us-gaap ContractWithCustomerLiabilityRevenueRecognized Contract with Customer, Liability, Revenue Recognized USD 61.51M 2020-01-01 2020-12-31 2020 FY 10-K 2021-02-25 0001439222-21-000029
us-gaap ContractWithCustomerPerformanceObligationSatisfiedInPreviousPeriod Contract with Customer, Performance Obligation Satisfied in Previous Period USD 0 2020-01-01 2020-12-31 2020 FY 10-K 2021-02-25 0001439222-21-000029
us-gaap ContractWithCustomerReceivableAfterAllowanceForCreditLossCurrent Contract with Customer, Receivable, after Allowance for Credit Loss, Current USD 25.25M 2026-09-30 2026 Q3 10-Q 2026-11-05 0001439222-26-000131
us-gaap ContractWithCustomerReceivableAllowanceForCreditLoss Contract with Customer, Receivable, Allowance for Credit Loss USD 3.26M 2026-09-30 2026 Q3 10-Q 2026-11-05 0001439222-26-000131
us-gaap ConversionOfStockAmountConverted1 Conversion of Stock, Amount Converted USD 115.92M 2013-01-01 2013-12-31 2015 FY 10-K 2016-02-26 0001193125-16-481973
us-gaap ConvertiblePreferredStockSharesIssuedUponConversion Convertible Preferred Stock, Shares Issued upon Conversion shares 19.73M 2014-12-31 2014 FY 10-K 2015-02-24 0001193125-15-060046
us-gaap CostOfGoodsAndServicesSold Cost of Goods and Services Sold USD 6.84M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-05 0001439222-26-000131
us-gaap CostsAndExpenses Costs and Expenses USD 418.61M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-05 0001439222-26-000131
us-gaap CurrentFederalTaxExpenseBenefit Current Federal Tax Expense (Benefit) USD -444,000 2014-01-01 2014-12-31 2016 FY 10-K 2017-02-16 0001193125-17-046795
us-gaap CurrentForeignTaxExpenseBenefit Current Foreign Tax Expense (Benefit) USD 0 2016-01-01 2016-12-31 2016 FY 10-K 2017-02-16 0001193125-17-046795
us-gaap CurrentIncomeTaxExpenseBenefit Current Income Tax Expense (Benefit) USD -426,000 2014-01-01 2014-12-31 2016 FY 10-K 2017-02-16 0001193125-17-046795
us-gaap CurrentStateAndLocalTaxExpenseBenefit Current State and Local Tax Expense (Benefit) USD 18,000 2014-01-01 2014-12-31 2016 FY 10-K 2017-02-16 0001193125-17-046795
us-gaap DebtConversionConvertedInstrumentAmount1 Debt Conversion, Converted Instrument, Amount USD 2.00M 2008-01-01 2009-12-31 2014 FY 10-K 2015-02-24 0001193125-15-060046
us-gaap DebtSecuritiesAvailableForSaleAllowanceForCreditLoss Debt Securities, Available-for-sale, Allowance for Credit Loss USD 0 2026-09-30 2026 Q3 10-Q 2026-11-05 0001439222-26-000131
us-gaap DebtSecuritiesAvailableForSaleAmortizedCostAllowanceForCreditLossExcludingAccruedInterest DebtSecuritiesAvailableForSaleAmortizedCostAllowanceForCreditLossExcludingAccruedInterest USD 0 2021-09-30 2021 Q3 10-Q 2021-11-03 0001439222-21-000073
us-gaap DebtSecuritiesAvailableForSaleAmortizedCostExcludingAccruedInterestBeforeAllowanceForCreditLoss DebtSecuritiesAvailableForSaleAmortizedCostExcludingAccruedInterestBeforeAllowanceForCreditLoss USD 996.16M 2021-09-30 2021 Q3 10-Q 2021-11-03 0001439222-21-000073
us-gaap DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsNumberOfPositions Debt Securities, Available-for-sale, Continuous Unrealized Loss Position, Less than 12 Months, Number of Positions security 156 2026-09-30 2026 Q3 10-Q 2026-11-05 0001439222-26-000131
us-gaap DebtSecuritiesAvailableForSaleExcludingAccruedInterest DebtSecuritiesAvailableForSaleExcludingAccruedInterest USD 995.97M 2021-09-30 2021 Q3 10-Q 2021-11-03 0001439222-21-000073
us-gaap DebtSecuritiesAvailableForSaleExcludingAccruedInterestCurrent DebtSecuritiesAvailableForSaleExcludingAccruedInterestCurrent USD 865.83M 2021-09-30 2021 Q3 10-Q 2021-11-03 0001439222-21-000073
us-gaap DebtSecuritiesAvailableForSaleExcludingAccruedInterestNoncurrent DebtSecuritiesAvailableForSaleExcludingAccruedInterestNoncurrent USD 130.14M 2021-09-30 2021 Q3 10-Q 2021-11-03 0001439222-21-000073
us-gaap DebtSecuritiesAvailableForSaleRealizedGainLoss Debt Securities, Available-for-sale, Realized Gain (Loss) USD 0 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-05 0001439222-26-000131
us-gaap DebtSecuritiesAvailableForSaleUnrealizedLossPosition Debt Securities, Available-for-sale, Unrealized Loss Position USD 663.20M 2026-09-30 2026 Q3 10-Q 2026-11-05 0001439222-26-000131
us-gaap DebtSecuritiesAvailableForSaleUnrealizedLossPositionNumberOfPositions Debt Securities, Available-for-sale, Unrealized Loss Position, Number of Positions security 0 2026-09-30 2026 Q3 10-Q 2026-11-05 0001439222-26-000131
us-gaap DecreaseInRestrictedCash Decrease in Restricted Cash USD 571,000 2014-01-01 2014-12-31 2016 FY 10-K 2017-02-16 0001193125-17-046795
us-gaap DeferredCompensationSharebasedArrangementsLiabilityClassifiedNoncurrent Deferred Compensation Share-based Arrangements, Liability, Classified, Noncurrent USD 6,000 2013-12-31 2013 FY 10-K 2014-03-18 0001193125-14-104521
us-gaap DeferredCompensationShareBasedArrangementsLiabilityCurrent Deferred Compensation Share-based Arrangements, Liability, Current USD 9,000 2013-12-31 2013 FY 10-K 2014-03-18 0001193125-14-104521
us-gaap DeferredFederalIncomeTaxExpenseBenefit Deferred Federal Income Tax Expense (Benefit) USD 0 2016-01-01 2016-12-31 2016 FY 10-K 2017-02-16 0001193125-17-046795
us-gaap DeferredForeignIncomeTaxExpenseBenefit Deferred Foreign Income Tax Expense (Benefit) USD 0 2016-01-01 2016-12-31 2016 FY 10-K 2017-02-16 0001193125-17-046795
us-gaap DeferredIncomeTaxesAndTaxCredits Deferred Income Taxes and Tax Credits USD 3.84M 2013-01-01 2013-12-31 2015 FY 10-K 2016-02-26 0001193125-16-481973
us-gaap DeferredIncomeTaxExpenseBenefit Deferred Income Tax Expense (Benefit) USD 0 2016-01-01 2016-12-31 2016 FY 10-K 2017-02-16 0001193125-17-046795
us-gaap DeferredRentCreditCurrent Deferred Rent Credit, Current USD 306,000 2020-03-31 2020 Q1 10-Q 2020-04-30 0001439222-20-000039
us-gaap DeferredRentCreditNoncurrent Deferred Rent Credit, Noncurrent USD 491,000 2020-06-30 2020 Q2 10-Q 2020-07-30 0001439222-20-000059
us-gaap DeferredRevenue Deferred Revenue USD 124.18M 2018-01-01 2018 Q2 10-Q 2018-08-02 0001439222-18-000014
us-gaap DeferredRevenueAdditions Deferred Revenue, Additions USD 121.20M 2014-01-01 2014-12-31 2014 FY 10-K 2015-02-24 0001193125-15-060046
us-gaap DeferredRevenueCurrent Deferred Revenue, Current USD 41.13M 2018-06-30 2018 Q2 10-Q 2018-08-02 0001439222-18-000014
us-gaap DeferredRevenueNoncurrent Deferred Revenue, Noncurrent USD 72.41M 2018-06-30 2018 Q2 10-Q 2018-08-02 0001439222-18-000014
us-gaap DeferredStateAndLocalIncomeTaxExpenseBenefit Deferred State and Local Income Tax Expense (Benefit) USD 0 2016-01-01 2016-12-31 2016 FY 10-K 2017-02-16 0001193125-17-046795
us-gaap DeferredTaxAssetsDeferredIncome Deferred Tax Assets, Deferred Income USD 0 2020-12-31 2020 FY 10-K 2021-02-25 0001439222-21-000029
us-gaap DeferredTaxAssetsGoodwillAndIntangibleAssets Deferred Tax Assets, Goodwill and Intangible Assets USD 13.30M 2025-12-31 2025 FY 10-K 2026-02-12 0001439222-26-000025
us-gaap DeferredTaxAssetsGross Deferred Tax Assets, Gross USD 373.53M 2025-12-31 2025 FY 10-K 2026-02-12 0001439222-26-000025
us-gaap DeferredTaxAssetsInProcessResearchAndDevelopment Deferred Tax Assets, in Process Research and Development USD 86.41M 2025-12-31 2025 FY 10-K 2026-02-12 0001439222-26-000025
us-gaap DeferredTaxAssetsLiabilitiesNet Deferred Tax Assets, Net USD 0 2025-12-31 2025 FY 10-K 2026-02-12 0001439222-26-000025
us-gaap DeferredTaxAssetsNet Deferred Tax Assets, Net of Valuation Allowance USD 8.41M 2016-12-31 2016 FY 10-K 2017-02-16 0001193125-17-046795
us-gaap DeferredTaxAssetsNetCurrent Deferred Tax Assets, Net of Valuation Allowance, Current USD 1.25M 2012-12-31 2013 FY 10-K 2014-03-18 0001193125-14-104521
us-gaap DeferredTaxAssetsNetNoncurrent Deferred Tax Assets, Net of Valuation Allowance, Noncurrent USD 2.71M 2012-12-31 2013 FY 10-K 2014-03-18 0001193125-14-104521
us-gaap DeferredTaxAssetsOperatingLossCarryforwards Deferred Tax Assets, Operating Loss Carryforwards USD 134.12M 2025-12-31 2025 FY 10-K 2026-02-12 0001439222-26-000025
us-gaap DeferredTaxAssetsOther Deferred Tax Assets, Other USD 325,000 2014-12-31 2014 FY 10-K 2015-02-24 0001193125-15-060046
us-gaap DeferredTaxAssetsTaxCreditCarryforwards Deferred Tax Assets, Tax Credit Carryforwards USD 103.91M 2025-12-31 2025 FY 10-K 2026-02-12 0001439222-26-000025
us-gaap DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost Deferred Tax Assets, Tax Deferred Expense, Compensation and Benefits, Share-based Compensation Cost USD 18.38M 2025-12-31 2025 FY 10-K 2026-02-12 0001439222-26-000025
us-gaap DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsDeferredRent Deferred Tax Assets, Tax Deferred Expense, Reserves and Accruals, Deferred Rent USD 0 2019-12-31 2019 FY 10-K 2020-02-19 0001439222-20-000014
us-gaap DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsReserves Deferred Tax Assets, Tax Deferred Expense, Reserves and Accruals, Reserves USD 8.63M 2025-12-31 2025 FY 10-K 2026-02-12 0001439222-26-000025
us-gaap DeferredTaxAssetsValuationAllowance Deferred Tax Assets, Valuation Allowance USD 365.62M 2025-12-31 2025 FY 10-K 2026-02-12 0001439222-26-000025
us-gaap DeferredTaxLiabilities Deferred Tax Liabilities, Net USD 8.41M 2016-12-31 2016 FY 10-K 2017-02-16 0001193125-17-046795
us-gaap DeferredTaxLiabilitiesDeferredExpenseCapitalizedResearchAndDevelopmentCosts Deferred Tax Liabilities, Deferred Expense, Capitalized Research and Development Costs USD 244.90M 2024-12-31 2024 FY 10-K 2025-02-13 0001439222-25-000009
us-gaap DeferredTaxLiabilitiesLeasingArrangements Deferred Tax Liabilities, Leasing Arrangements USD 7.49M 2025-12-31 2025 FY 10-K 2026-02-12 0001439222-26-000025
us-gaap DeferredTaxLiabilitiesPropertyPlantAndEquipment Deferred Tax Liabilities, Property, Plant and Equipment USD 418,000 2025-12-31 2025 FY 10-K 2026-02-12 0001439222-26-000025
us-gaap DefinedBenefitPlanContributionsByEmployer Defined Benefit Plan, Plan Assets, Contributions by Employer USD 0 2013-01-01 2013-12-31 2013 FY 10-K 2014-03-18 0001193125-14-104521
us-gaap DefinedContributionPlanEmployerDiscretionaryContributionAmount Defined Contribution Plan, Employer Discretionary Contribution Amount USD 1.00M 2016-01-01 2016-12-31 2016 FY 10-K 2017-02-16 0001193125-17-046795
us-gaap DefinedContributionPlanEmployerMatchingContributionPercentOfMatch Defined Contribution Plan, Employer Matching Contribution, Percent of Match pure 1 2025-01-01 2025-12-31 2025 FY 10-K 2026-02-12 0001439222-26-000025
us-gaap DefinedContributionPlanMaximumAnnualContributionsPerEmployeePercent Defined Contribution Plan, Maximum Annual Contributions Per Employee, Percent pure 0.04 2025-01-01 2025-12-31 2025 FY 10-K 2026-02-12 0001439222-26-000025
us-gaap Depreciation Depreciation USD 5.20M 2025-01-01 2025-12-31 2025 FY 10-K 2026-02-12 0001439222-26-000025
us-gaap DepreciationDepletionAndAmortization Depreciation, Depletion and Amortization USD 8.09M 2019-01-01 2019-12-31 2019 FY 10-K 2020-02-19 0001439222-20-000014
us-gaap DiscontinuedOperationTaxEffectOfDiscontinuedOperation Discontinued Operation, Tax Effect of Discontinued Operation USD 0 2022-01-01 2022-09-30 2022 Q3 10-Q 2022-11-03 0001439222-22-000099
us-gaap DisposalGroupIncludingDiscontinuedOperationAssetsNoncurrent Disposal Group, Including Discontinued Operation, Assets, Noncurrent USD 0 2021-12-31 2021 FY 10-K 2022-02-24 0001439222-22-000024
us-gaap DividendsPayableCurrentAndNoncurrent Dividends Payable USD 0 2016-12-31 2016 FY 10-K 2017-02-16 0001193125-17-046795
us-gaap DueFromRelatedPartiesCurrent Due from Related Parties, Current USD 4.84M 2017-06-30 2017 Q2 10-Q 2017-08-08 0001439222-17-000007
us-gaap EarningsPerShareBasic Earnings Per Share, Basic USD/shares -4.46 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-05 0001439222-26-000131
us-gaap EarningsPerShareBasicAndDiluted Earnings Per Share, Basic and Diluted USD/shares -4.74 2020-01-01 2020-12-31 2020 FY 10-K 2021-02-25 0001439222-21-000029
us-gaap EarningsPerShareDiluted Earnings Per Share, Diluted USD/shares -4.46 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-05 0001439222-26-000131
us-gaap EffectiveIncomeTaxRateContinuingOperations Effective Income Tax Rate Reconciliation, Percent pure 0.002 2025-01-01 2025-12-31 2025 FY 10-K 2026-02-12 0001439222-26-000025
us-gaap EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate Effective Income Tax Rate Reconciliation, at Federal Statutory Income Tax Rate, Percent pure 0.21 2025-01-01 2025-12-31 2025 FY 10-K 2026-02-12 0001439222-26-000025
us-gaap EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance Effective Income Tax Rate Reconciliation, Change in Deferred Tax Assets Valuation Allowance, Percent pure -0.23 2025-01-01 2025-12-31 2025 FY 10-K 2026-02-12 0001439222-26-000025
us-gaap EffectiveIncomeTaxRateReconciliationChangeInEnactedTaxRate Effective Income Tax Rate Reconciliation, Change in Enacted Tax Rate, Percent pure 0 2019-01-01 2019-12-31 2019 FY 10-K 2020-02-19 0001439222-20-000014
us-gaap EffectiveIncomeTaxRateReconciliationForeignIncomeTaxRateDifferential Effective Income Tax Rate Reconciliation, Foreign Income Tax Rate Differential, Percent pure 0 2021-01-01 2021-12-31 2021 FY 10-K 2022-02-24 0001439222-22-000024
us-gaap EffectiveIncomeTaxRateReconciliationNondeductibleExpense Effective Income Tax Rate Reconciliation, Nondeductible Expense, Percent pure 0.006 2024-01-01 2024-12-31 2025 FY 10-K 2026-02-12 0001439222-26-000025
us-gaap EffectiveIncomeTaxRateReconciliationNondeductibleExpenseOther Effective Income Tax Rate Reconciliation, Nondeductible Expense, Other, Percent pure -0.001 2025-01-01 2025-12-31 2025 FY 10-K 2026-02-12 0001439222-26-000025
us-gaap EffectiveIncomeTaxRateReconciliationNondeductibleExpenseShareBasedCompensationCost Effective Income Tax Rate Reconciliation, Nondeductible Expense, Share-based Payment Arrangement, Percent pure -0.017 2025-01-01 2025-12-31 2025 FY 10-K 2026-02-12 0001439222-26-000025
us-gaap EffectiveIncomeTaxRateReconciliationOtherAdjustments Effective Income Tax Rate Reconciliation, Other Adjustments, Percent pure 0.002 2025-01-01 2025-12-31 2025 FY 10-K 2026-02-12 0001439222-26-000025
us-gaap EffectiveIncomeTaxRateReconciliationOtherReconcilingItemsPercent Effective Income Tax Rate Reconciliation,Other Reconciling Items, Percent pure -0.001 2016-01-01 2016-12-31 2016 FY 10-K 2017-02-16 0001193125-17-046795
us-gaap EffectiveIncomeTaxRateReconciliationShareBasedCompensationExcessTaxBenefitPercent Effective Income Tax Rate Reconciliation, Tax Expense (Benefit), Share-based Payment Arrangement, Percent pure 0.001 2024-01-01 2024-12-31 2025 FY 10-K 2026-02-12 0001439222-26-000025
us-gaap EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes Effective Income Tax Rate Reconciliation, State and Local Income Taxes, Percent pure 0 2025-01-01 2025-12-31 2025 FY 10-K 2026-02-12 0001439222-26-000025
us-gaap EffectiveIncomeTaxRateReconciliationTaxCredits Effective Income Tax Rate Reconciliation, Tax Credit, Percent pure -0.019 2014-01-01 2014-12-31 2014 FY 10-K 2015-02-24 0001193125-15-060046
us-gaap EffectiveIncomeTaxRateReconciliationTaxCreditsResearch Effective Income Tax Rate Reconciliation, Tax Credit, Research, Percent pure -0.015 2025-01-01 2025-12-31 2025 FY 10-K 2026-02-12 0001439222-26-000025
us-gaap EmployeeRelatedLiabilitiesCurrent Employee-related Liabilities, Current USD 19.07M 2026-09-30 2026 Q3 10-Q 2026-11-05 0001439222-26-000131
us-gaap EmployeeServiceShareBasedCompensationTaxBenefitFromCompensationExpense Share-based Payment Arrangement, Expense, Tax Benefit USD 0 2025-01-01 2025-12-31 2025 FY 10-K 2026-02-12 0001439222-26-000025
us-gaap FairValueAssetsLevel1ToLevel2TransfersAmount Fair Value, Assets, Level 1 to Level 2 Transfers, Amount USD 4.00M 2017-09-30 2017 Q3 10-Q 2017-11-01 0001439222-17-000009
us-gaap FairValueAssetsLevel2ToLevel1TransfersAmount Fair Value, Assets, Level 2 to Level 1 Transfers, Amount USD 10.00M 2017-09-30 2017 Q3 10-Q 2017-11-01 0001439222-17-000009
us-gaap FairValueLiabilitiesLevel1ToLevel2TransfersAmount Fair Value, Liabilities, Level 1 to Level 2 Transfers, Amount USD 0 2017-09-30 2017 Q3 10-Q 2017-11-01 0001439222-17-000009
us-gaap FairValueLiabilitiesLevel2ToLevel1TransfersAmount Fair Value, Liabilities, Level 2 to Level 1 Transfers, Amount USD 0 2017-09-30 2017 Q3 10-Q 2017-11-01 0001439222-17-000009
us-gaap FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetValue Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Asset Value USD 0 2017-03-31 2017 Q1 10-Q 2017-05-04 0001193125-17-157874
us-gaap FinanceLeaseLiabilityCurrent Finance Lease, Liability, Current USD 0 2022-12-31 2022 FY 10-K 2023-02-23 0001439222-23-000039
us-gaap FinanceLeaseLiabilityNoncurrent Finance Lease, Liability, Noncurrent USD 0 2022-12-31 2022 FY 10-K 2023-02-23 0001439222-23-000039
us-gaap FinanceLeasePrincipalPayments Finance Lease, Principal Payments USD 0 2024-01-01 2024-12-31 2024 FY 10-K 2025-02-13 0001439222-25-000009
us-gaap FinanceLeaseRightOfUseAsset Finance Lease, Right-of-Use Asset, after Accumulated Amortization USD 0 2022-12-31 2022 FY 10-K 2023-02-23 0001439222-23-000039
us-gaap FinancingReceivableAllowanceForCreditLosses Financing Receivable, Allowance for Credit Loss USD 0 2020-09-30 2020 Q3 10-Q 2020-11-05 0001439222-20-000069
us-gaap GainLossOnDispositionOfAssets1 Gain (Loss) on Disposition of Assets USD -1.05M 2019-01-01 2019-12-31 2019 FY 10-K 2020-02-19 0001439222-20-000014
us-gaap GainLossOnSaleOfBusiness Gain (Loss) on Disposition of Business USD 2.97M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-05 0001439222-26-000131
us-gaap GainLossOnSaleOfPropertyPlantEquipment Gain (Loss) on Disposition of Property Plant Equipment USD 0 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-05 0001439222-26-000131
us-gaap GainOnSaleOfInvestments Gain on Sale of Investments USD 28,000 2023-01-01 2023-09-30 2023 Q3 10-Q 2023-11-02 0001439222-23-000140
us-gaap GeneralAndAdministrativeExpense General and Administrative Expense USD 88.90M 2022-01-01 2022-09-30 2022 Q3 10-Q 2022-11-03 0001439222-22-000099
us-gaap IncomeLossFromContinuingOperations Income (Loss) from Continuing Operations, Net of Tax, Attributable to Parent USD -352.09M 2023-01-01 2023-12-31 2023 FY 10-K 2024-02-15 0001439222-24-000035
us-gaap IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic Income (Loss) from Continuing Operations before Income Taxes, Domestic USD -413.81M 2025-01-01 2025-12-31 2025 FY 10-K 2026-02-12 0001439222-26-000025
us-gaap IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest USD -413.80M 2025-01-01 2025-12-31 2025 FY 10-K 2026-02-12 0001439222-26-000025
us-gaap IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign Income (Loss) from Continuing Operations before Income Taxes, Foreign USD 9,000 2025-01-01 2025-12-31 2025 FY 10-K 2026-02-12 0001439222-26-000025
us-gaap IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments Income (Loss) from Continuing Operations before Equity Method Investments, Income Taxes, Noncontrolling Interest USD -327.45M 2020-01-01 2020-12-31 2020 FY 10-K 2021-02-25 0001439222-21-000029
us-gaap IncomeLossFromContinuingOperationsPerBasicShare Income (Loss) from Continuing Operations, Per Basic Share USD/shares -6.33 2023-01-01 2023-12-31 2023 FY 10-K 2024-02-15 0001439222-24-000035
us-gaap IncomeLossFromContinuingOperationsPerDilutedShare Income (Loss) from Continuing Operations, Per Diluted Share USD/shares -6.33 2023-01-01 2023-12-31 2023 FY 10-K 2024-02-15 0001439222-24-000035
us-gaap IncomeLossFromDiscontinuedOperationsNetOfTaxAttributableToReportingEntity Income (Loss) from Discontinued Operations, Net of Tax, Attributable to Parent USD 0 2023-01-01 2023-12-31 2023 FY 10-K 2024-02-15 0001439222-24-000035
us-gaap IncomeLossFromDiscontinuedOperationsNetOfTaxPerBasicShare Income (Loss) from Discontinued Operations and Disposal of Discontinued Operations, Net of Tax, Per Basic Share USD/shares 0 2023-01-01 2023-12-31 2023 FY 10-K 2024-02-15 0001439222-24-000035
us-gaap IncomeLossFromDiscontinuedOperationsNetOfTaxPerDilutedShare Income (Loss) from Discontinued Operations and Disposal of Discontinued Operations, Net of Tax, Per Diluted Share USD/shares 0 2023-01-01 2023-12-31 2023 FY 10-K 2024-02-15 0001439222-24-000035
us-gaap IncomeTaxesPaid Income Taxes Paid USD 43.15M 2024-01-01 2024-12-31 2024 FY 10-K 2025-02-13 0001439222-25-000009
us-gaap IncomeTaxesPaidNet Income Taxes Paid, Net USD 328,000 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-05 0001439222-26-000131
us-gaap IncomeTaxesReceivable Income Taxes Receivable, Current USD 3.84M 2014-12-31 2015 FY 10-K 2016-02-26 0001193125-16-481973
us-gaap IncomeTaxExaminationIncreaseDecreaseInLiabilityFromPriorYear Income Tax Examination, Increase (Decrease) in Liability from Prior Year USD 700,000 2014-03-31 2014 Q1 10-Q 2014-05-09 0001193125-14-192411
us-gaap IncomeTaxExaminationLiabilityRefundAdjustmentFromSettlementWithTaxingAuthority Income Tax Examination, Liability (Refund) Adjustment from Settlement with Taxing Authority USD -400,000 2014-09-30 2015 Q3 10-Q 2015-11-06 0001193125-15-370225
us-gaap IncomeTaxExaminationPenaltiesAndInterestAccrued Income Tax Examination, Penalties and Interest Accrued USD 700,000 2014-06-30 2014 Q2 10-Q 2014-08-07 0001193125-14-300949
us-gaap IncomeTaxExaminationPenaltiesAndInterestExpense Income Tax Examination, Penalties and Interest Expense USD 1.50M 2014-01-01 2014-01-31 2016 Q3 10-Q 2016-11-03 0001193125-16-758835
us-gaap IncomeTaxExpenseBenefit Income Tax Expense (Benefit) USD -1.02M 2025-01-01 2025-12-31 2025 FY 10-K 2026-02-12 0001439222-26-000025
us-gaap IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance Effective Income Tax Rate Reconciliation, Change in Deferred Tax Assets Valuation Allowance, Amount USD 95.03M 2025-01-01 2025-12-31 2025 FY 10-K 2026-02-12 0001439222-26-000025
us-gaap IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate Effective Income Tax Rate Reconciliation at Federal Statutory Income Tax Rate, Amount USD -86.90M 2025-01-01 2025-12-31 2025 FY 10-K 2026-02-12 0001439222-26-000025
us-gaap IncomeTaxReconciliationNondeductibleExpenseOther Effective Income Tax Rate Reconciliation, Nondeductible Expense, Other, Amount USD 592,000 2025-01-01 2025-12-31 2025 FY 10-K 2026-02-12 0001439222-26-000025
us-gaap IncomeTaxReconciliationNondeductibleExpenseShareBasedCompensationCost Effective Income Tax Rate Reconciliation, Nondeductible Expense, Share-based Payment Arrangement, Amount USD 7.15M 2025-01-01 2025-12-31 2025 FY 10-K 2026-02-12 0001439222-26-000025
us-gaap IncomeTaxReconciliationOtherAdjustments Effective Income Tax Rate Reconciliation, Other Adjustments, Amount USD -863,000 2025-01-01 2025-12-31 2025 FY 10-K 2026-02-12 0001439222-26-000025
us-gaap IncomeTaxReconciliationStateAndLocalIncomeTaxes Effective Income Tax Rate Reconciliation, State and Local Income Taxes, Amount USD -153,000 2025-01-01 2025-12-31 2025 FY 10-K 2026-02-12 0001439222-26-000025
us-gaap IncomeTaxReconciliationTaxCreditsResearch Effective Income Tax Rate Reconciliation, Tax Credit, Research, Amount USD 6.22M 2025-01-01 2025-12-31 2025 FY 10-K 2026-02-12 0001439222-26-000025
us-gaap IncreaseDecreaseInAccountsAndOtherReceivables Increase (Decrease) in Accounts and Other Receivables USD 0 2018-01-01 2018-06-30 2018 Q2 10-Q 2018-08-02 0001439222-18-000014
us-gaap IncreaseDecreaseInAccountsPayable Increase (Decrease) in Accounts Payable USD 984,000 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-05 0001439222-26-000131
us-gaap IncreaseDecreaseInAccountsReceivable Increase (Decrease) in Accounts Receivable USD 14.68M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-05 0001439222-26-000131
us-gaap IncreaseDecreaseInAccruedIncomeTaxesPayable Increase (Decrease) in Income Taxes Payable USD 0 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-05 0001439222-26-000131
us-gaap IncreaseDecreaseInAccruedLiabilitiesAndOtherOperatingLiabilities Increase (Decrease) in Accrued Liabilities and Other Operating Liabilities USD -7.45M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-05 0001439222-26-000131
us-gaap IncreaseDecreaseInContractWithCustomerAsset Increase (Decrease) in Contract with Customer, Asset USD 7.64M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-05 0001439222-26-000131
us-gaap IncreaseDecreaseInContractWithCustomerLiability Increase (Decrease) in Contract with Customer, Liability USD 0 2023-01-01 2023-03-31 2023 Q1 10-Q 2023-05-04 0001439222-23-000065
us-gaap IncreaseDecreaseInDeferredCharges Increase (Decrease) in Deferred Charges USD 0 2020-01-01 2020-12-31 2020 FY 10-K 2021-02-25 0001439222-21-000029
us-gaap IncreaseDecreaseInDeferredRevenue Increase (Decrease) in Deferred Revenue USD -10.64M 2018-01-01 2018-06-30 2018 Q2 10-Q 2018-08-02 0001439222-18-000014
us-gaap IncreaseDecreaseInDueFromRelatedPartiesCurrent Increase (Decrease) in Due from Related Parties, Current USD -44,000 2017-01-01 2017-06-30 2017 Q2 10-Q 2017-08-08 0001439222-17-000007
us-gaap IncreaseDecreaseInInventories Increase (Decrease) in Inventories USD 4.92M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-05 0001439222-26-000131
us-gaap IncreaseDecreaseInOperatingLeaseLiability IncreaseDecreaseInOperatingLeaseLiability USD -13.68M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-05 0001439222-26-000131
us-gaap IncreaseDecreaseInOtherDeferredLiability Increase (Decrease) in Other Deferred Liability USD -55,000 2014-01-01 2014-06-30 2014 Q2 10-Q 2014-08-07 0001193125-14-300949
us-gaap IncreaseDecreaseInOtherNoncurrentLiabilities Increase (Decrease) in Other Noncurrent Liabilities USD 150,000 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-05 0001439222-26-000131
us-gaap IncreaseDecreaseInOtherOperatingLiabilities Increase (Decrease) in Other Operating Liabilities USD -790,000 2025-01-01 2025-12-31 2025 FY 10-K 2026-02-12 0001439222-26-000025
us-gaap IncreaseDecreaseInOtherReceivables Increase (Decrease) in Other Receivables USD 0 2023-01-01 2023-09-30 2023 Q3 10-Q 2023-11-02 0001439222-23-000140
us-gaap IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets Increase (Decrease) in Prepaid Expense and Other Assets USD 7.37M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-05 0001439222-26-000131
us-gaap IncreaseDecreaseInPrepaidExpense Increase (Decrease) in Prepaid Expense USD 2.76M 2014-01-01 2014-09-30 2014 Q3 10-Q 2014-11-07 0001193125-14-403316
us-gaap IncreaseDecreaseInUnbilledReceivables Increase (Decrease) in Unbilled Receivables USD -476,000 2014-01-01 2014-06-30 2014 Q2 10-Q 2014-08-07 0001193125-14-300949
us-gaap InterestIncomeExpenseNonoperatingNet Interest Income (Expense), Nonoperating, Net USD 29.41M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-05 0001439222-26-000131
us-gaap InterestRevenueExpenseNet Interest Revenue (Expense), Net USD 504,000 2021-01-01 2021-09-30 2021 Q3 10-Q 2021-11-03 0001439222-21-000073
us-gaap InventoryFinishedGoodsNetOfReserves Inventory, Finished Goods, Net of Reserves USD 2.72M 2026-09-30 2026 Q3 10-Q 2026-11-05 0001439222-26-000131
us-gaap InventoryGross Inventory, Gross USD 37.84M 2026-09-30 2026 Q3 10-Q 2026-11-05 0001439222-26-000131
us-gaap InventoryNet Inventory, Net USD 37.84M 2026-09-30 2026 Q3 10-Q 2026-11-05 0001439222-26-000131
us-gaap InventoryNoncurrent Inventory, Noncurrent USD 5.60M 2026-06-30 2026 Q2 10-Q 2026-07-30 0001439222-26-000118
us-gaap InventoryRawMaterialsNetOfReserves Inventory, Raw Materials, Net of Reserves USD 374,000 2026-09-30 2026 Q3 10-Q 2026-11-05 0001439222-26-000131
us-gaap InventoryWorkInProcessNetOfReserves Inventory, Work in Process, Net of Reserves USD 34.74M 2026-09-30 2026 Q3 10-Q 2026-11-05 0001439222-26-000131
us-gaap InventoryWriteDown Inventory Write-down USD 0 2020-01-01 2020-12-31 2020 FY 10-K 2021-02-25 0001439222-21-000029
us-gaap InvestmentIncomeInterest Investment Income, Interest USD 12.79M 2022-01-01 2022-12-31 2022 FY 10-K 2023-02-23 0001439222-23-000039
us-gaap InvestmentIncomeNet Investment Income, Net USD 16.34M 2023-01-01 2023-06-30 2023 Q2 10-Q 2023-08-03 0001439222-23-000119
us-gaap LeaseAndRentalExpense Operating Leases, Rent Expense USD 11.40M 2018-01-01 2018-12-31 2020 FY 10-K 2021-02-25 0001439222-21-000029
us-gaap LeaseIncentiveReceivable Lease Incentive Receivable USD 20.50M 2016-12-31 2016 FY 10-K 2017-02-16 0001193125-17-046795
us-gaap LesseeOperatingLeaseLiabilityPaymentsDue Lessee, Operating Lease, Liability, to be Paid USD 27.61M 2026-09-30 2026 Q3 10-Q 2026-11-05 0001439222-26-000131
us-gaap LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive Lessee, Operating Lease, Liability, to be Paid, after Year Five USD 0 2023-12-31 2023 FY 10-K 2024-02-15 0001439222-24-000035
us-gaap LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths Lessee, Operating Lease, Liability, to be Paid, Year One USD 20.75M 2026-09-30 2026 Q3 10-Q 2026-11-05 0001439222-26-000131
us-gaap LesseeOperatingLeaseLiabilityPaymentsDueYearFive Lessee, Operating Lease, Liability, to be Paid, Year Five USD 3.48M 2023-12-31 2023 FY 10-K 2024-02-15 0001439222-24-000035
us-gaap LesseeOperatingLeaseLiabilityPaymentsDueYearFour Lessee, Operating Lease, Liability, to be Paid, Year Four USD 3.48M 2024-12-31 2024 FY 10-K 2025-02-13 0001439222-25-000009
us-gaap LesseeOperatingLeaseLiabilityPaymentsDueYearThree Lessee, Operating Lease, Liability, to be Paid, Year Three USD 0 2026-03-31 2026 Q1 10-Q 2026-04-29 0001439222-26-000073
us-gaap LesseeOperatingLeaseLiabilityPaymentsDueYearTwo Lessee, Operating Lease, Liability, to be Paid, Year Two USD 3.48M 2026-09-30 2026 Q3 10-Q 2026-11-05 0001439222-26-000131
us-gaap LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear Lessee, Operating Lease, Liability, to be Paid, Remainder of Fiscal Year USD 3.38M 2026-09-30 2026 Q3 10-Q 2026-11-05 0001439222-26-000131
us-gaap LesseeOperatingLeaseLiabilityUndiscountedExcessAmount Lessee, Operating Lease, Liability, Undiscounted Excess Amount USD 1.08M 2026-09-30 2026 Q3 10-Q 2026-11-05 0001439222-26-000131
us-gaap LessorOperatingLeasePaymentsToBeReceived Lessor, Operating Lease, Payments to be Received USD 1.49M 2026-09-30 2026 Q3 10-Q 2026-11-05 0001439222-26-000131
us-gaap LessorOperatingLeasePaymentsToBeReceivedNextTwelveMonths Lessor, Operating Lease, Payment to be Received, Year One USD 1.05M 2026-09-30 2026 Q3 10-Q 2026-11-05 0001439222-26-000131
us-gaap LessorOperatingLeasePaymentsToBeReceivedRemainderOfFiscalYear Lessor, Operating Lease, Payment to be Received, Remainder of Fiscal Year USD 260,000 2026-09-30 2026 Q3 10-Q 2026-11-05 0001439222-26-000131
us-gaap LessorOperatingLeasePaymentsToBeReceivedThreeYears Lessor, Operating Lease, Payment to be Received, Year Three USD 67,000 2025-12-31 2025 FY 10-K 2026-02-12 0001439222-26-000025
us-gaap LessorOperatingLeasePaymentsToBeReceivedTwoYears Lessor, Operating Lease, Payment to be Received, Year Two USD 178,000 2026-09-30 2026 Q3 10-Q 2026-11-05 0001439222-26-000131
us-gaap LettersOfCreditOutstandingAmount Letters of Credit Outstanding, Amount USD 2.90M 2026-09-30 2026 Q3 10-Q 2026-11-05 0001439222-26-000131
us-gaap Liabilities Liabilities USD 84.70M 2026-09-30 2026 Q3 10-Q 2026-11-05 0001439222-26-000131
us-gaap LiabilitiesAndStockholdersEquity Liabilities and Equity USD 1.06B 2026-09-30 2026 Q3 10-Q 2026-11-05 0001439222-26-000131
us-gaap LiabilitiesCurrent Liabilities, Current USD 77.59M 2026-09-30 2026 Q3 10-Q 2026-11-05 0001439222-26-000131
us-gaap LiabilitiesOfDisposalGroupIncludingDiscontinuedOperationCurrent Disposal Group, Including Discontinued Operation, Liabilities, Current USD 0 2021-12-31 2021 FY 10-K 2022-02-24 0001439222-22-000024
us-gaap LiabilitiesOfDisposalGroupIncludingDiscontinuedOperationNoncurrent Disposal Group, Including Discontinued Operation, Liabilities, Noncurrent USD 0 2021-12-31 2021 FY 10-K 2022-02-24 0001439222-22-000024
us-gaap LiabilityForUncertainTaxPositionsCurrent Liability for Uncertainty in Income Taxes, Current USD 0 2017-03-31 2017 Q1 10-Q 2017-05-04 0001193125-17-157874
us-gaap LicenseAndServicesRevenue License and Services Revenue (Deprecated 2018-01-31) USD 7.34M 2018-01-01 2018-03-31 2018 Q1 10-Q 2018-05-04 0001439222-18-000009
us-gaap LicenseCosts License Costs (Deprecated 2018-01-31) USD 70,000 2016-01-01 2016-12-31 2016 FY 10-K 2017-02-16 0001193125-17-046795
us-gaap MarketableSecuritiesRealizedGainLoss Marketable Securities, Realized Gain (Loss) USD 0 2022-01-01 2022-03-31 2022 Q1 10-Q 2022-05-05 0001439222-22-000040
us-gaap MarketableSecuritiesUnrealizedGainLoss Marketable Securities, Unrealized Gain (Loss) USD 5,000 2016-01-01 2016-12-31 2016 FY 10-K 2017-02-16 0001193125-17-046795
us-gaap NetCashProvidedByUsedInFinancingActivities Net Cash Provided by (Used in) Financing Activities USD 9.41M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-05 0001439222-26-000131
us-gaap NetCashProvidedByUsedInFinancingActivitiesContinuingOperations Net Cash Provided by (Used in) Financing Activities, Continuing Operations USD 2.35M 2022-01-01 2022-12-31 2022 FY 10-K 2023-02-23 0001439222-23-000039
us-gaap NetCashProvidedByUsedInInvestingActivities Net Cash Provided by (Used in) Investing Activities USD 265.48M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-05 0001439222-26-000131
us-gaap NetCashProvidedByUsedInInvestingActivitiesContinuingOperations Net Cash Provided by (Used in) Investing Activities, Continuing Operations USD 239.57M 2023-01-01 2023-12-31 2023 FY 10-K 2024-02-15 0001439222-24-000035
us-gaap NetCashProvidedByUsedInOperatingActivities Net Cash Provided by (Used in) Operating Activities USD -235.47M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-05 0001439222-26-000131
us-gaap NetCashProvidedByUsedInOperatingActivitiesContinuingOperations Net Cash Provided by (Used in) Operating Activities, Continuing Operations USD -296.06M 2023-01-01 2023-12-31 2023 FY 10-K 2024-02-15 0001439222-24-000035
us-gaap NetIncomeLoss Net Income (Loss) Attributable to Parent USD -264.86M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-05 0001439222-26-000131
us-gaap NetIncomeLossAvailableToCommonStockholdersBasic Net Income (Loss) Available to Common Stockholders, Basic USD -94.63M 2021-10-01 2021-12-31 2021 FY 10-K 2022-02-24 0001439222-22-000024
us-gaap NumberOfOperatingSegments Number of Operating Segments segment 1 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-05 0001439222-26-000131
us-gaap NumberOfReportableSegments Number of Reportable Segments segment 1 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-05 0001439222-26-000131
us-gaap OperatingExpenses Operating Expenses USD 456.87M 2018-01-01 2018-12-31 2020 FY 10-K 2021-02-25 0001439222-21-000029
us-gaap OperatingIncomeLoss Operating Income (Loss) USD -297.74M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-05 0001439222-26-000131
us-gaap OperatingLeaseCost Operating Lease, Cost USD 11.42M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-05 0001439222-26-000131
us-gaap OperatingLeaseLiability Operating Lease, Liability USD 26.53M 2026-09-30 2026 Q3 10-Q 2026-11-05 0001439222-26-000131
us-gaap OperatingLeaseLiabilityCurrent Operating Lease, Liability, Current USD 19.65M 2026-09-30 2026 Q3 10-Q 2026-11-05 0001439222-26-000131
us-gaap OperatingLeaseLiabilityNoncurrent Operating Lease, Liability, Noncurrent USD 6.88M 2026-09-30 2026 Q3 10-Q 2026-11-05 0001439222-26-000131
us-gaap OperatingLeasePayments Operating Lease, Payments USD 15.13M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-05 0001439222-26-000131
us-gaap OperatingLeaseRightOfUseAsset Operating Lease, Right-of-Use Asset USD 20.49M 2026-09-30 2026 Q3 10-Q 2026-11-05 0001439222-26-000131
us-gaap OperatingLeaseRightOfUseAssetAmortizationExpense Operating Lease, Right-of-Use Asset, Amortization Expense USD 9.97M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-05 0001439222-26-000131
us-gaap OperatingLeasesFutureMinimumPaymentsDue Operating Leases, Future Minimum Payments Due USD 91.29M 2018-12-31 2019 FY 10-K 2020-02-19 0001439222-20-000014
us-gaap OperatingLeasesFutureMinimumPaymentsDueCurrent Operating Leases, Future Minimum Payments Due, Next Twelve Months USD 12.76M 2018-12-31 2019 FY 10-K 2020-02-19 0001439222-20-000014
us-gaap OperatingLeasesFutureMinimumPaymentsDueInFiveYears Operating Leases, Future Minimum Payments, Due in Five Years USD 17.14M 2018-12-31 2019 FY 10-K 2020-02-19 0001439222-20-000014
us-gaap OperatingLeasesFutureMinimumPaymentsDueInFourYears Operating Leases, Future Minimum Payments, Due in Four Years USD 15.55M 2018-12-31 2019 FY 10-K 2020-02-19 0001439222-20-000014
us-gaap OperatingLeasesFutureMinimumPaymentsDueInThreeYears Operating Leases, Future Minimum Payments, Due in Three Years USD 13.47M 2018-12-31 2019 FY 10-K 2020-02-19 0001439222-20-000014
us-gaap OperatingLeasesFutureMinimumPaymentsDueInTwoYears Operating Leases, Future Minimum Payments, Due in Two Years USD 13.13M 2018-12-31 2019 FY 10-K 2020-02-19 0001439222-20-000014
us-gaap OperatingLeasesFutureMinimumPaymentsDueThereafter Operating Leases, Future Minimum Payments, Due Thereafter USD 19.22M 2018-12-31 2019 FY 10-K 2020-02-19 0001439222-20-000014
us-gaap OperatingLeasesFutureMinimumPaymentsRemainderOfFiscalYear Operating Leases, Future Minimum Payments, Remainder of Fiscal Year USD 4.99M 2014-12-31 2014 FY 10-K 2015-02-24 0001193125-15-060046
us-gaap OperatingLeaseWeightedAverageDiscountRatePercent Operating Lease, Weighted Average Discount Rate, Percent pure 0.057 2026-09-30 2026 Q3 10-Q 2026-11-05 0001439222-26-000131
us-gaap OtherAccruedLiabilitiesCurrent Other Accrued Liabilities, Current USD 6.00M 2026-09-30 2026 Q3 10-Q 2026-11-05 0001439222-26-000131
us-gaap OtherAssetsNoncurrent Other Assets, Noncurrent USD 4.08M 2026-09-30 2026 Q3 10-Q 2026-11-05 0001439222-26-000131
us-gaap OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax OCI, Debt Securities, Available-for-Sale, Gain (Loss), after Adjustment and Tax USD 0 2017-01-01 2017-06-30 2017 Q2 10-Q 2017-08-08 0001439222-17-000007
us-gaap OtherComprehensiveIncomeLossAvailableForSaleSecuritiesBeforeReclassificationAdjustmentsTax OCI, Debt Securities, Available-for-Sale, Gain (Loss), before Adjustment, Tax USD 2.50M 2026-07-01 2026-09-30 2026 Q3 10-Q 2026-11-05 0001439222-26-000131
us-gaap OtherComprehensiveIncomeLossNetOfTax Other Comprehensive Income (Loss), Net of Tax USD -4.58M 2022-07-01 2022-09-30 2022 Q3 10-Q 2022-11-03 0001439222-22-000099
us-gaap OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax OCI, Debt Securities, Available-for-Sale, Unrealized Holding Gain (Loss), before Adjustment, after Tax USD -6.48M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-05 0001439222-26-000131
us-gaap OtherDepreciationAndAmortization Other Depreciation and Amortization USD 4.17M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-05 0001439222-26-000131
us-gaap OtherLiabilitiesCurrent Other Liabilities, Current USD 6,000 2014-12-31 2015 FY 10-K 2016-02-26 0001193125-16-481973
us-gaap OtherLiabilitiesNoncurrent Other Liabilities, Noncurrent USD 240,000 2026-09-30 2026 Q3 10-Q 2026-11-05 0001439222-26-000131
us-gaap OtherNonoperatingIncomeExpense Other Nonoperating Income (Expense) USD 504,000 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-05 0001439222-26-000131
us-gaap OtherOperatingIncomeExpenseNet Other Operating Income (Expense), Net USD 2.97M 2022-01-01 2022-03-31 2022 Q1 10-Q 2022-05-05 0001439222-22-000040
us-gaap OtherReceivablesNetCurrent Other Receivables, Net, Current USD 3.77M 2022-09-30 2022 Q3 10-Q 2022-11-03 0001439222-22-000099
us-gaap PaymentsForRepurchaseOfCommonStock Payments for Repurchase of Common Stock USD 0 2022-01-01 2022-09-30 2022 Q3 10-Q 2022-11-03 0001439222-22-000099
us-gaap PaymentsForRepurchaseOfEquity Payments for Repurchase of Equity USD 0 2023-01-01 2023-12-31 2023 FY 10-K 2024-02-15 0001439222-24-000035
us-gaap PaymentsForRepurchaseOfInitialPublicOffering Payments for Repurchase of Initial Public Offering USD 2.39M 2013-01-01 2013-12-31 2013 FY 10-K 2014-03-18 0001193125-14-104521
us-gaap PaymentsOfStockIssuanceCosts Payments of Stock Issuance Costs USD 0 2020-01-01 2020-12-31 2020 FY 10-K 2021-02-25 0001439222-21-000029
us-gaap PaymentsToAcquireAvailableForSaleSecurities Payments to Acquire Available-for-sale Securities USD 933.32M 2018-01-01 2018-12-31 2018 FY 10-K 2019-02-14 0001439222-19-000004
us-gaap PaymentsToAcquireAvailableForSaleSecuritiesDebt Payments to Acquire Debt Securities, Available-for-sale USD 387.25M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-05 0001439222-26-000131
us-gaap PaymentsToAcquireMarketableSecurities Payments to Acquire Marketable Securities USD 430.62M 2020-01-01 2020-09-30 2020 Q3 10-Q 2020-11-05 0001439222-20-000069
us-gaap PaymentsToAcquirePropertyPlantAndEquipment Payments to Acquire Property, Plant, and Equipment USD 3.16M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-05 0001439222-26-000131
us-gaap PreferredStockDividendsIncomeStatementImpact Preferred Stock Dividends, Income Statement Impact USD 4.16M 2013-01-01 2013-12-31 2015 FY 10-K 2016-02-26 0001193125-16-481973
us-gaap PreferredStockParOrStatedValuePerShare Preferred Stock, Par or Stated Value Per Share USD/shares 0.001 2026-09-30 2026 Q3 10-Q 2026-11-05 0001439222-26-000131
us-gaap PreferredStockSharesAuthorized Preferred Stock, Shares Authorized shares 25.00M 2026-09-30 2026 Q3 10-Q 2026-11-05 0001439222-26-000131
us-gaap PreferredStockSharesIssued Preferred Stock, Shares Issued shares 0 2026-09-30 2026 Q3 10-Q 2026-11-05 0001439222-26-000131
us-gaap PreferredStockSharesOutstanding Preferred Stock, Shares Outstanding shares 0 2026-09-30 2026 Q3 10-Q 2026-11-05 0001439222-26-000131
us-gaap PreferredStockValue Preferred Stock, Value, Issued USD 0 2022-09-30 2022 Q3 10-Q 2022-11-03 0001439222-22-000099
us-gaap PreferredStockValueOutstanding Preferred Stock, Value, Outstanding USD 0 2026-09-30 2026 Q3 10-Q 2026-11-05 0001439222-26-000131
us-gaap PrepaidExpenseAndOtherAssetsCurrent Prepaid Expense and Other Assets, Current USD 51.35M 2026-09-30 2026 Q3 10-Q 2026-11-05 0001439222-26-000131
us-gaap ProceedsFromDivestitureOfBusinesses Proceeds from Divestiture of Businesses USD 0 2025-01-01 2025-12-31 2025 FY 10-K 2026-02-12 0001439222-26-000025
us-gaap ProceedsFromIssuanceInitialPublicOffering Proceeds from Issuance Initial Public Offering USD 113.37M 2013-01-01 2013-12-31 2013 FY 10-K 2014-03-18 0001193125-14-104521
us-gaap ProceedsFromIssuanceOfCommonStock Proceeds from Issuance of Common Stock USD 0 2021-01-01 2021-12-31 2021 FY 10-K 2022-02-24 0001439222-22-000024
us-gaap ProceedsFromIssuanceOfConvertiblePreferredStock Proceeds from Issuance of Convertible Preferred Stock USD 77.30M 2011-01-01 2011-12-31 2013 FY 10-K 2014-03-18 0001193125-14-104521
us-gaap ProceedsFromIssuanceOfPrivatePlacement Proceeds from Issuance of Private Placement USD 12.75M 2013-01-01 2013-12-31 2015 FY 10-K 2016-02-26 0001193125-16-481973
us-gaap ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlansIncludingStockOptions Proceeds, Issuance of Shares, Share-based Payment Arrangement, Including Option Exercised USD 9.41M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-05 0001439222-26-000131
us-gaap ProceedsFromIssuanceOrSaleOfEquity Proceeds from Issuance or Sale of Equity USD 72,000 2013-01-01 2013-06-30 2013 Q2 10-Q 2013-09-05 0001193125-13-358412
us-gaap ProceedsFromSaleAndMaturityOfAvailableForSaleSecurities Proceeds from Sale and Maturity of Debt Securities, Available-for-sale USD 680.89M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-05 0001439222-26-000131
us-gaap ProceedsFromSaleAndMaturityOfMarketableSecurities Proceeds from Sale and Maturity of Marketable Securities USD 448.87M 2020-01-01 2020-09-30 2020 Q3 10-Q 2020-11-05 0001439222-20-000069
us-gaap ProceedsFromSaleOfAvailableForSaleSecurities Proceeds from Sale of Available-for-sale Securities USD 13.00M 2011-01-01 2011-12-31 2013 FY 10-K 2014-03-18 0001193125-14-104521
us-gaap ProceedsFromSaleOfMachineryAndEquipment Proceeds from Sale of Machinery and Equipment USD 0 2025-01-01 2025-12-31 2025 FY 10-K 2026-02-12 0001439222-26-000025
us-gaap ProceedsFromSaleOfPropertyPlantAndEquipment Proceeds from Sale of Property, Plant, and Equipment USD 1.32M 2023-01-01 2023-09-30 2023 Q3 10-Q 2023-11-02 0001439222-23-000140
us-gaap ProceedsFromStockOptionsExercised Proceeds from Stock Options Exercised USD 7.86M 2016-01-01 2016-12-31 2016 FY 10-K 2017-02-16 0001193125-17-046795
us-gaap PropertyPlantAndEquipmentGross Property, Plant and Equipment, Gross USD 70.89M 2025-12-31 2025 FY 10-K 2026-02-12 0001439222-26-000025
us-gaap PropertyPlantAndEquipmentNet Property, Plant and Equipment, Net USD 10.36M 2026-09-30 2026 Q3 10-Q 2026-11-05 0001439222-26-000131
us-gaap RealizedInvestmentGainsLosses Realized Investment Gains (Losses) USD 95,000 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-05 0001439222-26-000131
us-gaap ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax Reclassification from Accumulated Other Comprehensive Income, Current Period, Net of Tax USD 0 2018-01-01 2018-09-30 2018 Q3 10-Q 2018-11-01 0001439222-18-000018
us-gaap ReimbursementRevenue Reimbursement Revenue (Deprecated 2018-01-31) USD 33.10M 2015-01-01 2015-03-31 2015 Q1 10-Q 2015-05-11 0001193125-15-181968
us-gaap ResearchAndDevelopmentArrangementContractToPerformForOthersCompensationEarned Research and Development Arrangement, Contract to Perform for Others, Compensation Earned USD 0 2019-01-01 2019-12-31 2019 FY 10-K 2020-02-19 0001439222-20-000014
us-gaap ResearchAndDevelopmentExpense Research and Development Expense USD 255.39M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-05 0001439222-26-000131
us-gaap RestrictedCashAndCashEquivalents Restricted Cash and Cash Equivalents USD 571,000 2013-12-31 2013 FY 10-K 2014-03-18 0001193125-14-104521
us-gaap RestrictedCashAndCashEquivalentsNoncurrent Restricted Cash and Cash Equivalents, Noncurrent USD 571,000 2013-12-31 2014 FY 10-K 2015-02-24 0001193125-15-060046
us-gaap RetainedEarningsAccumulatedDeficit Retained Earnings (Accumulated Deficit) USD -826.56M 2026-09-30 2026 Q3 10-Q 2026-11-05 0001439222-26-000131
us-gaap RevenueFromContractWithCustomerExcludingAssessedTax Revenue from Contract with Customer, Excluding Assessed Tax USD 120.88M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-05 0001439222-26-000131
us-gaap RevenueFromGrants Revenue from Grants (Deprecated 2018-01-31) USD 34,000 2012-01-01 2012-12-31 2014 FY 10-K 2015-02-24 0001193125-15-060046
us-gaap RevenueFromRelatedParties Revenue from Related Parties USD 7.34M 2018-01-01 2018-03-31 2018 Q1 10-Q 2018-05-04 0001439222-18-000009
us-gaap RevenueRecognitionMilestoneMethodRevenueRecognized Revenue Recognition, Milestone Method, Revenue Recognized USD 0 2019-01-01 2019-03-31 2019 Q1 10-Q 2019-05-02 0001439222-19-000009
us-gaap RevenueRecognitionMultipleDeliverableArrangementsDeterminationOfSellingPriceAmount Revenue Recognition, Multiple-deliverable Arrangements, Determination of Selling Price, Amount USD 124.30M 2014-01-01 2014-06-30 2014 Q2 10-Q 2014-08-07 0001193125-14-300949
us-gaap RevenueRemainingPerformanceObligation Revenue, Remaining Performance Obligation, Amount USD 4.50M 2020-09-30 2020 Q3 10-Q 2020-11-05 0001439222-20-000069
us-gaap Revenues Revenues USD 30.01M 2018-10-01 2018-12-31 2018 FY 10-K 2019-02-14 0001439222-19-000004
us-gaap RightOfUseAssetObtainedInExchangeForFinanceLeaseLiability Right-of-Use Asset Obtained in Exchange for Finance Lease Liability USD 0 2023-01-01 2023-12-31 2023 FY 10-K 2024-02-15 0001439222-24-000035
us-gaap RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability Right-of-Use Asset Obtained in Exchange for Operating Lease Liability USD 0 2021-01-01 2021-12-31 2021 FY 10-K 2022-02-24 0001439222-22-000024
us-gaap RoyaltyExpense Royalty Expense USD 0 2015-01-01 2015-12-31 2016 FY 10-K 2017-02-16 0001193125-17-046795
us-gaap RoyaltyIncomeNonoperating Royalty Income, Nonoperating USD 0 2024-01-01 2024-12-31 2024 FY 10-K 2025-02-13 0001439222-25-000009
us-gaap RoyaltyRevenue Royalty Revenue (Deprecated 2018-01-31) USD 2.99M 2018-01-01 2018-06-30 2018 Q2 10-Q 2018-08-02 0001439222-18-000014
us-gaap SecurityDepositLiability Security Deposit Liability USD 200,000 2026-09-30 2026 Q3 10-Q 2026-11-05 0001439222-26-000131
us-gaap SellingGeneralAndAdministrativeExpense Selling, General and Administrative Expense USD 156.38M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-05 0001439222-26-000131
us-gaap ShareBasedCompensation Share-based Payment Arrangement, Noncash Expense USD 48.15M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-05 0001439222-26-000131
us-gaap SharebasedCompensationArrangementBySharebasedPaymentAwardEquityInstrumentsOtherThanOptionsAggregateIntrinsicValueOutstanding Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Aggregate Intrinsic Value, Outstanding USD 0 2013-09-30 2014 Q3 10-Q 2014-11-07 0001193125-14-403316
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Grants in Period shares 0 2013-01-01 2013-03-31 2014 Q1 10-Q 2014-05-09 0001193125-14-192411
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Vested in Period shares 7,500 2017-01-01 2017-12-31 2017 FY 10-K 2018-02-14 0001439222-18-000004
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Expected Dividend Rate pure 0 2025-01-01 2025-12-31 2025 FY 10-K 2026-02-12 0001439222-26-000025
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Expected Volatility Rate pure 0.542 2025-01-01 2025-12-31 2025 FY 10-K 2026-02-12 0001439222-26-000025
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Risk Free Interest Rate pure 0.04 2025-01-01 2025-12-31 2025 FY 10-K 2026-02-12 0001439222-26-000025
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardMaximumNumberOfSharesPerEmployee Share-based Compensation Arrangement by Share-based Payment Award, Maximum Number of Shares Per Employee shares 327,272 2014-01-01 2014-06-30 2014 Q2 10-Q 2014-08-07 0001193125-14-300949
us-gaap SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1 Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercisable, Intrinsic Value USD 1.66M 2025-12-31 2025 FY 10-K 2026-02-12 0001439222-26-000025
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercisable, Number shares 4.68M 2026-09-30 2026 Q3 10-Q 2026-11-05 0001439222-26-000131
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercisable, Weighted Average Exercise Price USD/shares 40.88 2026-09-30 2026 Q3 10-Q 2026-11-05 0001439222-26-000131
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercises in Period, Intrinsic Value USD 60.40M 2014-01-01 2014-12-31 2014 FY 10-K 2015-02-24 0001193125-15-060046
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExpirationsInPeriod Share-based Compensation Arrangement by Share-based Payment Award, Options, Expirations in Period shares 251,567 2025-01-01 2025-12-31 2025 FY 10-K 2026-02-12 0001439222-26-000025
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod Share-based Compensation Arrangement by Share-based Payment Award, Options, Forfeitures in Period shares 221,212 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-05 0001439222-26-000131
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Gross shares 851,777 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-05 0001439222-26-000131
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Weighted Average Grant Date Fair Value USD/shares 27.26 2014-01-01 2014-12-31 2014 FY 10-K 2015-02-24 0001193125-15-060046
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Intrinsic Value USD 2.05M 2025-12-31 2025 FY 10-K 2026-02-12 0001439222-26-000025
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Number shares 6.41M 2026-09-30 2026 Q3 10-Q 2026-11-05 0001439222-26-000131
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Weighted Average Exercise Price USD/shares 38.34 2026-09-30 2026 Q3 10-Q 2026-11-05 0001439222-26-000131
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingAggregateIntrinsicValue Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested and Expected to Vest, Outstanding, Aggregate Intrinsic Value USD 2.05M 2025-12-31 2025 FY 10-K 2026-02-12 0001439222-26-000025
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested and Expected to Vest, Outstanding, Number shares 6.41M 2026-09-30 2026 Q3 10-Q 2026-11-05 0001439222-26-000131
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageExercisePrice Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested and Expected to Vest, Outstanding, Weighted Average Exercise Price USD/shares 38.34 2026-09-30 2026 Q3 10-Q 2026-11-05 0001439222-26-000131
us-gaap ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice Share-based Compensation Arrangements by Share-based Payment Award, Options, Exercises in Period, Weighted Average Exercise Price USD/shares 30.09 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-05 0001439222-26-000131
us-gaap ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExpirationsInPeriodWeightedAverageExercisePrice Share-based Compensation Arrangements by Share-based Payment Award, Options, Expirations in Period, Weighted Average Exercise Price USD/shares 105.27 2025-01-01 2025-12-31 2025 FY 10-K 2026-02-12 0001439222-26-000025
us-gaap ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice Share-based Compensation Arrangements by Share-based Payment Award, Options, Forfeitures in Period, Weighted Average Exercise Price USD/shares 46.28 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-05 0001439222-26-000131
us-gaap ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice Share-based Compensation Arrangements by Share-based Payment Award, Options, Grants in Period, Weighted Average Exercise Price USD/shares 29.98 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-05 0001439222-26-000131
us-gaap SharesIssuedPricePerShare Shares Issued, Price Per Share USD/shares 67 2018-01-31 2018 Q3 10-Q 2018-11-01 0001439222-18-000018
us-gaap StockholdersEquity Stockholders' Equity Attributable to Parent USD 979.34M 2026-09-30 2026 Q3 10-Q 2026-11-05 0001439222-26-000131
us-gaap StockholdersEquityNoteStockSplitConversionRatio1 Stockholders' Equity Note, Stock Split, Conversion Ratio pure 2.75 2015-01-01 2015-12-31 2015 FY 10-K 2016-02-26 0001193125-16-481973
us-gaap StockholdersEquityOther Stockholders' Equity, Other USD 391,000 2018-01-01 2018-12-31 2020 FY 10-K 2021-02-25 0001439222-21-000029
us-gaap StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities Stock Issued During Period, Shares, Conversion of Convertible Securities shares 19.73M 2013-07-28 2013-07-29 2014 Q3 10-Q 2014-11-07 0001193125-14-403316
us-gaap StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans Stock Issued During Period, Shares, Employee Stock Purchase Plans shares 0 2014-01-01 2014-06-30 2014 Q2 10-Q 2014-08-07 0001193125-14-300949
us-gaap StockIssuedDuringPeriodSharesNewIssues Stock Issued During Period, Shares, New Issues shares 9.49M 2019-11-01 2019-11-30 2020 FY 10-K 2021-02-25 0001439222-21-000029
us-gaap StockIssuedDuringPeriodSharesStockOptionsExercised Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercises in Period shares 195,618 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-05 0001439222-26-000131
us-gaap StockIssuedDuringPeriodValueConversionOfConvertibleSecurities Stock Issued During Period, Value, Conversion of Convertible Securities USD 115.92M 2013-01-01 2013-12-31 2015 FY 10-K 2016-02-26 0001193125-16-481973
us-gaap StockIssuedDuringPeriodValueNewIssues Stock Issued During Period, Value, New Issues USD 277.20M 2019-01-01 2019-12-31 2021 FY 10-K 2022-02-24 0001439222-22-000024
us-gaap StockIssuedDuringPeriodValueStockOptionsExercised Stock Issued During Period, Value, Stock Options Exercised USD 4.18M 2026-07-01 2026-09-30 2026 Q3 10-Q 2026-11-05 0001439222-26-000131
us-gaap StockRepurchaseProgramAuthorizedAmount1 Stock Repurchase Program, Authorized Amount USD 1.20B 2021-03-25 2022 FY 10-K 2023-02-23 0001439222-23-000039
us-gaap StraightLineRent Straight Line Rent USD 24,000 2014-01-01 2014-03-31 2014 Q1 10-Q 2014-05-09 0001193125-14-192411
us-gaap SubleaseIncome Sublease Income USD 500,000 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-05 0001439222-26-000131
us-gaap TaxCutsAndJobsActOf2017IncomeTaxExpenseBenefit Tax Cuts and Jobs Act, Income Tax Expense (Benefit) USD 90.00M 2018-01-01 2018-12-31 2019 FY 10-K 2020-02-19 0001439222-20-000014
us-gaap TaxesPayableCurrent Taxes Payable, Current USD 0 2025-12-31 2025 FY 10-K 2026-02-12 0001439222-26-000025
us-gaap TenantImprovements Tenant Improvements USD 3.10M 2016-12-31 2016 FY 10-K 2017-02-16 0001193125-17-046795
us-gaap TreasuryStockCommonShares Treasury Stock, Common, Shares shares 16.22M 2026-09-30 2026 Q3 10-Q 2026-11-05 0001439222-26-000131
us-gaap TreasuryStockShares Treasury Stock, Shares shares 16.22M 2023-03-31 2023 Q1 10-Q 2023-05-04 0001439222-23-000065
us-gaap TreasuryStockValue Treasury Stock, Value USD 802.49M 2026-09-30 2026 Q3 10-Q 2026-11-05 0001439222-26-000131
us-gaap TreasuryStockValueAcquiredCostMethod Treasury Stock, Value, Acquired, Cost Method USD 802.49M 2021-01-01 2021-12-31 2023 FY 10-K 2024-02-15 0001439222-24-000035
us-gaap UnbilledContractsReceivable Unbilled Contracts Receivable USD 476,000 2013-12-31 2014 Q2 10-Q 2014-08-07 0001193125-14-300949
us-gaap UnrecognizedTaxBenefits Unrecognized Tax Benefits USD 35.79M 2025-12-31 2025 FY 10-K 2026-02-12 0001439222-26-000025
us-gaap UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestAccrued Unrecognized Tax Benefits, Income Tax Penalties and Interest Accrued USD 0 2025-12-31 2025 FY 10-K 2026-02-12 0001439222-26-000025
us-gaap UnrecognizedTaxBenefitsIncreasesResultingFromCurrentPeriodTaxPositions Unrecognized Tax Benefits, Increase Resulting from Current Period Tax Positions USD 2.87M 2025-01-01 2025-12-31 2025 FY 10-K 2026-02-12 0001439222-26-000025
us-gaap UnrecognizedTaxBenefitsIncreasesResultingFromPriorPeriodTaxPositions Unrecognized Tax Benefits, Increase Resulting from Prior Period Tax Positions USD 1.33M 2025-01-01 2025-12-31 2025 FY 10-K 2026-02-12 0001439222-26-000025
us-gaap ValuationAllowanceDeferredTaxAssetChangeInAmount Valuation Allowance, Deferred Tax Asset, Increase (Decrease), Amount USD 90.05M 2025-01-01 2025-12-31 2025 FY 10-K 2026-02-12 0001439222-26-000025
us-gaap WeightedAverageNumberOfDilutedSharesOutstanding Weighted Average Number of Shares Outstanding, Diluted shares 59.33M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-05 0001439222-26-000131
us-gaap WeightedAverageNumberOfShareOutstandingBasicAndDiluted Weighted Average Number of Shares Outstanding, Basic and Diluted shares 69.00M 2020-01-01 2020-12-31 2020 FY 10-K 2021-02-25 0001439222-21-000029
us-gaap WeightedAverageNumberOfSharesOutstandingBasic Weighted Average Number of Shares Outstanding, Basic shares 59.33M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-05 0001439222-26-000131

Financialist News Desk

Our desk turns official SEC filings into news. Each story is checked against the original filing. About us → · Editorial standards →